| Year |
Citation |
Score |
| 2019 |
Beaulieu J, Borrelli E, Carlsson A, Caron MG, Civelli O, Espinoza S, Fisone G, Gainetdinov RR, Grandy DK, Kebabian JW, Langer SZ, Missale MC, Neve KA, Scatton B, Schwartz J, ... Sedvall G, et al. Dopamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f20/2019.4 |
0.333 |
|
| 2008 |
Jönsson EG, Saetre P, Edman-Ahlbom B, Sillén A, Gunnar A, Andreou D, Agartz I, Sedvall G, Hall H, Terenius L. Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1695-9. PMID 18781277 DOI: 10.1007/s00702-008-0113-9 |
0.307 |
|
| 2004 |
Jönsson EG, Bah J, Melke J, Abou Jamra R, Schumacher J, Westberg L, Ivo R, Cichon S, Propping P, Nöthen MM, Eriksson E, Sedvall GC. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Bmc Psychiatry. 4: 4. PMID 15102340 DOI: 10.1186/1471-244X-4-4 |
0.317 |
|
| 2004 |
Damberg M, Berggård C, Farde L, Sedvall GC, Jönsson EG. Transcription factor AP-2beta genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 537-45. PMID 15057523 DOI: 10.1007/s00702-003-0097-4 |
0.469 |
|
| 2003 |
Carmine A, Buervenich S, Galter D, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Chowdari KV, Nimgaonkar VL, Anvret M, Sydow O, Olson L. NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 120: 51-7. PMID 12815740 DOI: 10.1002/Ajmg.B.20033 |
0.373 |
|
| 2003 |
Jönsson EG, Sedvall GC, Nöthen MM, Cichon S. Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses. Schizophrenia Research. 61: 111-9. PMID 12648742 DOI: 10.1016/S0920-9964(02)00287-6 |
0.332 |
|
| 2003 |
Carmine A, Chheda MG, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Anvret M, Buervenich S, Olson L. Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits. Psychiatric Genetics. 13: 23-8. PMID 12605097 DOI: 10.1097/01.ypg.0000056680.82896.22 |
0.436 |
|
| 2003 |
Hall H, Arnborg S, Agartz I, Sillén A, Jonsson E, Edman B, Nyman H, Terenius L, Sedvall G. P.2.114 Cross-domain analyses in schizophrenia — results from human brain informatics studies European Neuropsychopharmacology. 13: S330. DOI: 10.1016/S0924-977X(03)92067-0 |
0.301 |
|
| 2002 |
Karlsson P, Farde L, Halldin C, Sedvall G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. The American Journal of Psychiatry. 159: 761-7. PMID 11986129 DOI: 10.1176/Appi.Ajp.159.5.761 |
0.608 |
|
| 2002 |
Hall H, Arnborg S, Agartz I, Sedvall G. Data mining in schizophrenia in the Human Brain Informatics Project European Psychiatry. 17: 182. DOI: 10.1016/S0924-9338(02)80783-0 |
0.311 |
|
| 2002 |
Varnäs K, Hall H, Halldin C, Sedvall G. Autoradiographic localisation of 5-HT receptors in the human brain European Psychiatry. 17: 155. DOI: 10.1016/S0924-9338(02)80674-5 |
0.353 |
|
| 2002 |
Hall H, McNeil T, Arnborg S, Terenius L, Sedvall G. HUBIN — Human Brain Informatics: a database project on schizophrenia European Psychiatry. 17: 71. DOI: 10.1016/S0924-9338(02)80324-8 |
0.314 |
|
| 2001 |
Varnäs K, Hall H, Bonaventure P, Sedvall G. Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743. Brain Research. 915: 47-57. PMID 11578619 DOI: 10.1016/S0006-8993(01)02823-2 |
0.386 |
|
| 2001 |
Jönsson EG, Ivo R, Forslund K, Mattila-Evenden M, Rylander G, Cichon S, Propping P, Nöthen MM, Asberg M, Sedvall GC. No association between a promoter dopamine D(4) receptor gene variant and schizophrenia. American Journal of Medical Genetics. 105: 525-8. PMID 11496369 DOI: 10.1002/ajmg.1478 |
0.309 |
|
| 2001 |
Nobuhara K, Farde L, Halldin C, Karlsson P, Swahn CG, Olsson H, Bergström KA, Larsson SA, Schnell PO, McPherson DW, Savonen A, Hiltunen J, Sedvall G. SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP. European Journal of Nuclear Medicine. 28: 13-24. PMID 11202446 DOI: 10.1007/S002590000390 |
0.495 |
|
| 2001 |
Hall H, Hurd Y, Pauli S, Halldin C, Sedvall G. Human brain imaging post-mortem - Whole hemisphere technologies International Review of Psychiatry. 13: 12-17. DOI: 10.1080/09540260124940 |
0.427 |
|
| 2001 |
Hall H, Varnäs K, Werner T, Stenfors C, Sedvall G. Autoradiographic studies of the 5-HT1B/D receptors in the postmortem human brain using [3H]AR-A000002; Comparison with [3H]GR125743 European Neuropsychopharmacology. 11: S216. DOI: 10.1016/S0924-977X(01)80203-0 |
0.364 |
|
| 2000 |
Hall H, Farde L, Halldin C, Lundkvist C, Sedvall G. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907. Synapse (New York, N.Y.). 38: 421-31. PMID 11044889 DOI: 10.1002/1098-2396(20001215)38:4<421::Aid-Syn7>3.0.Co;2-X |
0.525 |
|
| 2000 |
Nobuhara K, Halldin C, Hall H, Karlsson P, Farde L, Hiltunen J, McPherson DW, Savonen A, Bergström KA, Pauli S, Swahn CG, Larsson SA, Schnell PO, Sedvall G. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease. Psychopharmacology. 149: 45-55. PMID 10789882 DOI: 10.1007/S002139900356 |
0.534 |
|
| 1999 |
Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, Asberg M, Propping P, Sedvall GC. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophrenia Research. 40: 31-6. PMID 10541004 DOI: 10.1016/S0920-9964(99)00033-X |
0.333 |
|
| 1999 |
Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry. 4: 290-6. PMID 10395223 DOI: 10.1038/Sj.Mp.4000532 |
0.554 |
|
| 1999 |
Sandell J, Halldin C, Hall H, Thorberg SO, Werner T, Sohn D, Sedvall G, Farde L. Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor. Nuclear Medicine and Biology. 26: 159-64. PMID 10100214 DOI: 10.1016/S0969-8051(98)00091-2 |
0.563 |
|
| 1999 |
Hall H, Halldin C, Guilloteau D, Chalon S, Emond P, Besnard J, Farde L, Sedvall G. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage. 9: 108-16. PMID 9918732 DOI: 10.1006/Nimg.1998.0366 |
0.553 |
|
| 1999 |
Pauli S, Hall H, Halldin C, Hurd Y, Sedvall G. Spatial visualization and relative quantification of D2- dopamine receptors in a human post mortem brain hemisphere European Neuropsychopharmacology. 9: 355. DOI: 10.1016/S0924-977X(99)80537-9 |
0.449 |
|
| 1999 |
Sedvall GC, Karlsson P. Pharmacological manipulation of D1-dopamine receptor function in schizophrenia Neuropsychopharmacology. 21: S181-S188. DOI: 10.1016/S0893-133X(99)00104-9 |
0.347 |
|
| 1998 |
Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J, Sedvall G, Farde L. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 2061-8. PMID 9867142 |
0.593 |
|
| 1998 |
Hall H, Halldin C, Farde L, Sedvall G. Whole hemisphere autoradiography of the postmortem human brain. Nuclear Medicine and Biology. 25: 715-9. PMID 9863555 DOI: 10.1016/S0969-8051(98)00053-5 |
0.573 |
|
| 1998 |
Caberlotto L, Fuxe K, Rimland JM, Sedvall G, Hurd YL. Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain. Neuroscience. 86: 167-78. PMID 9692752 DOI: 10.1016/S0306-4522(98)00039-6 |
0.351 |
|
| 1998 |
Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Research. 779: 58-74. PMID 9473588 DOI: 10.1016/S0006-8993(97)01078-0 |
0.429 |
|
| 1998 |
Hall H, Halldin C, Farde L, Sedvall G. Distribution of Serotonin Receptor Subtypes in the Post-Mortem Human Brain Neuroimage. 7: S291. DOI: 10.1016/S1053-8119(18)31124-8 |
0.492 |
|
| 1998 |
Hall H, Halldin C, Sandell J, Werner T, Thorberg O, Sedvall G. Autoradiographic studies of the labelling of 5-HT1A receptors in the post-mortem human brain using [11C]NAD-299 and [3H]NAD-299 European Neuropsychopharmacology. 8: S170. DOI: 10.1016/S0924-977X(98)80219-8 |
0.395 |
|
| 1998 |
Jönsson EG, Nöthen MM, Neidt H, Farde L, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density in vivo of healthy volunteers American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 497. |
0.36 |
|
| 1998 |
Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden MM, Åsberg M, Propping P, Sedvall GC. Association between a promoter poly-morphism in the dopamine D2 receptor gene and schizophrenia American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 497. |
0.327 |
|
| 1997 |
Svenningsson P, Hall H, Sedvall G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse (New York, N.Y.). 27: 322-35. PMID 9372555 DOI: 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E |
0.632 |
|
| 1997 |
Günther I, Hall H, Halldin C, Swahn CG, Farde L, Sedvall G. [125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain. Nuclear Medicine and Biology. 24: 629-34. PMID 9352533 DOI: 10.1016/S0969-8051(97)00081-4 |
0.464 |
|
| 1997 |
Hall H, Halldin C, Jerning E, Osterlund M, Farde L, Sedvall G. Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors. Nuclear Medicine and Biology. 24: 389-93. PMID 9290072 DOI: 10.1016/S0969-8051(97)80004-2 |
0.612 |
|
| 1997 |
Caberlotto L, Fuxe K, Sedvall G, Hurd YL. Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum. The European Journal of Neuroscience. 9: 1212-25. PMID 9215705 DOI: 10.1111/J.1460-9568.1997.Tb01476.X |
0.385 |
|
| 1997 |
Pauli S, Sedvall G. Three-dimensional visualization and quantification of the benzodiazepine receptor population within a living human brain using PET and MRI. European Archives of Psychiatry and Clinical Neuroscience. 247: 61-70. PMID 9177951 DOI: 10.1007/Bf02900195 |
0.414 |
|
| 1997 |
Ginovart N, Lundin A, Farde L, Halldin C, Bäckman L, Swahn CG, Pauli S, Sedvall G. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain : a Journal of Neurology. 120: 503-14. PMID 9126061 DOI: 10.1093/Brain/120.3.503 |
0.603 |
|
| 1997 |
Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA, Fletcher A, Cliffe IA, Barf T, Wikström H, Sedvall G. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Research. 745: 96-108. PMID 9037397 DOI: 10.1016/S0006-8993(96)01131-6 |
0.582 |
|
| 1997 |
Sedvall G. Dopamine D2 receptor imaging of antipsychotic drug action Psychiatry Research: Neuroimaging. 68: 176. DOI: 10.1016/S0925-4927(97)81574-0 |
0.33 |
|
| 1997 |
Sedvall G. What is wrong with dopamine receptors in schizophrenia Psychiatry Research: Neuroimaging. 68: 176. DOI: 10.1016/S0925-4927(97)81573-9 |
0.323 |
|
| 1997 |
Pauli S, Hall H, Halldin C, Sedvall G. Neuro-receptor imaging in threedimensions in vivo and in vitro: Application to dopamine and benzodiazepine receptors Schizophrenia Research. 24: 180. DOI: 10.1016/S0920-9964(97)82518-2 |
0.43 |
|
| 1997 |
Karlsson P, Farde L, Halldin C, Sedvall G. D1-Dopamine receptors in schizophrenia examined by pet Schizophrenia Research. 24: 178-179. DOI: 10.1016/S0920-9964(97)82513-3 |
0.608 |
|
| 1996 |
Oxenstierna G, Bergstrand G, Edman G, Flyckt L, Nybäck H, Sedvall G. Increased frequency of aberrant CSF circulation in schizophrenic patients compared to healthy volunteers. European Psychiatry : the Journal of the Association of European Psychiatrists. 11: 16-20. PMID 19698417 DOI: 10.1016/0924-9338(96)80454-8 |
0.301 |
|
| 1996 |
Hall H, Halldin C, Dijkstra D, Wikström H, Wise LD, Pugsley TA, Sokoloff P, Pauli S, Farde L, Sedvall G. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. Psychopharmacology. 128: 240-7. PMID 8972543 DOI: 10.1007/S002130050131 |
0.59 |
|
| 1996 |
Jönsson E, Sedvall G, Brené S, Gustavsson JP, Geijer T, Terenius L, Crocq MA, Lannfelt L, Tylec A, Sokoloff P, Schwartz JC, Wiesel FA. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biological Psychiatry. 40: 1032-43. PMID 8915563 DOI: 10.1016/0006-3223(95)00581-1 |
0.395 |
|
| 1996 |
Jönsson E, Brené S, Geijer T, Terenius L, Tylec A, Persson ML, Sedvall G. A search for association between schizophrenia and dopamine-related alleles. European Archives of Psychiatry and Clinical Neuroscience. 246: 297-304. PMID 8908411 DOI: 10.1007/BF02189022 |
0.437 |
|
| 1996 |
Sedvall GC. Neurobiological correlates of acute neuroleptic treatment. International Clinical Psychopharmacology. 11: 41-6. PMID 8803659 DOI: 10.1097/00004850-199605002-00007 |
0.325 |
|
| 1996 |
Hall H, Farde L, Halldin C, Hurd YL, Pauli S, Sedvall G. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse (New York, N.Y.). 23: 115-23. PMID 8723716 DOI: 10.1002/(Sici)1098-2396(199606)23:2<115::Aid-Syn7>3.0.Co;2-C |
0.617 |
|
| 1996 |
Sedvall G, Farde L. Dopamine receptors in schizophrenia. Lancet. 347: 264. PMID 8551909 DOI: 10.1016/S0140-6736(96)90440-7 |
0.578 |
|
| 1996 |
NORDSTRÖM A, FARDE L, NYBERG S, KARLSSON P, HALLDIN C, SEDVALL G. Dr. Nordström and Colleagues Reply American Journal of Psychiatry. 153: 1240-1240. DOI: 10.1176/Ajp.153.9.1240 |
0.407 |
|
| 1996 |
Karlsson P, Farde L, Halldin C, Sedvall G. Reduced D1-dopamine receptor binding in schizophrenia — Relation to psychopathology European Neuropsychopharmacology. 6: 212-213. DOI: 10.1016/0924-977X(96)88301-5 |
0.601 |
|
| 1996 |
Hall H, Lundkvist C, Halldin C, Pike V, McCarron J, Fletcher A, Cliffe I, Farde L, Sedvall G. Autoradiographic localization of 5-HT1A-receptors in the human brain European Neuropsychopharmacology. 6: 212. DOI: 10.1016/0924-977X(96)88297-6 |
0.548 |
|
| 1996 |
Hall H, Hurd Y, Suzuki M, Farde L, Halldin C, Sedvall G. Distribution of dopamine receptor subtypes in the post-mortem human brain European Neuropsychopharmacology. 6: 157. DOI: 10.1016/0924-977X(96)88033-3 |
0.6 |
|
| 1996 |
Ginovart N, Lundin A, Farde L, Halldin C, Swahn C, Pauli S, Sedvall G. In vivo examination of the Pre- and postsynaptic dopamine neurons in huntington's disease European Neuropsychopharmacology. 6: 130. DOI: 10.1016/0924-977X(96)87905-3 |
0.492 |
|
| 1996 |
Karlsson P, Farde L, Halldin C, Sedvall G. PET D1-receptor studies in schizophrenia European Psychiatry. 11: 231s-232s. DOI: 10.1016/0924-9338(96)88691-3 |
0.566 |
|
| 1996 |
Karlsson P, Farde L, Halldin C, Sedvall G. Decrease of D1-dopamine receptor binding in the frontal cortex of neuroleptic naive schizophrenic patients measured by PET Schizophrenia Research. 18: 198. DOI: 10.1016/0920-9964(96)85618-0 |
0.609 |
|
| 1995 |
Sedvall G, Pauli S, Karlsson P, Farde L, Nordström AL, Nyberg S, Halldin C. PET imaging of neuroreceptors in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 25-30. PMID 8775755 DOI: 10.1016/0924-977X(95)00021-G |
0.648 |
|
| 1995 |
Karlsson P, Smith L, Farde L, Härnryd C, Sedvall G, Wiesel FA. Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology. 121: 309-16. PMID 8584611 DOI: 10.1007/BF02246068 |
0.533 |
|
| 1995 |
Karlsson P, Sedvall G, Halldin C, Swahn CG, Farde L. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man. Psychopharmacology. 121: 300-8. PMID 8584610 DOI: 10.1007/Bf02246067 |
0.641 |
|
| 1995 |
Karlsson P, Farde L, Halldin C, Sedvall G, Ynddal L, Sloth-Nielsen M. Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man. Psychopharmacology. 119: 1-8. PMID 7675940 DOI: 10.1007/Bf02246046 |
0.613 |
|
| 1995 |
Sedvall G, Farde L. Chemical brain anatomy in schizophrenia. Lancet. 346: 743-9. PMID 7658878 DOI: 10.1016/S0140-6736(95)91508-7 |
0.418 |
|
| 1995 |
Sedvall G, Pauli S, Farde L, Karlsson P, Nyberg S, Nordström AL. Recent developments in PET scan imaging of neuroreceptors in schizophrenia. The Israel Journal of Psychiatry and Related Sciences. 32: 22-9. PMID 7622344 |
0.591 |
|
| 1995 |
Sedvall G, Farde L, Hall H, Halldin C, Karlsson P, Nordström AL, Nyberg S, Pauli S. Utilization of radioligands in schizophrenia research. Clinical Neuroscience (New York, N.Y.). 3: 112-21. PMID 7583617 |
0.592 |
|
| 1995 |
Nordström AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. The American Journal of Psychiatry. 152: 1444-9. PMID 7573582 DOI: 10.1176/Ajp.152.10.1444 |
0.582 |
|
| 1995 |
Hall H, Halldin C, Nyberg S, Farde L, Sedvall G. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 19-25. PMID 7542051 DOI: 10.1016/0924-977X(94)00127-W |
0.632 |
|
| 1995 |
Brené S, Hall H, Lindefors N, Karlsson P, Halldin C, Sedvall G. Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors. Neuroscience. 67: 37-48. PMID 7477907 DOI: 10.1016/0306-4522(95)00037-J |
0.442 |
|
| 1995 |
Jönsson E, Sedvall G, Brene S, Gustafsson JP, Geijer T, Terenius L, Crocq M-, Lannfelt L, Sokoloff P, Schwartz JC, Wiesel F-. Relationships between cerebrospinal fluid monoamine metabolites and dopamine-related genotypes in healthy volunteers Psychiatric Genetics. 5: 135. DOI: 10.1097/00041444-199505030-00018 |
0.361 |
|
| 1995 |
Farde L, Nordström A, Karlsson P, Halldin C, Sedvall G. Positron Emission Tomography Studies on Dopamine Receptors in Schizophrenia Clinical Neuropharmacology. 18: S121-S129. DOI: 10.1097/00002826-199501001-00014 |
0.582 |
|
| 1995 |
HALL H, FARDE L, HALLDIN C, NYBERG S, MOHELL N, JACKSON D, SEDVALL G. Extra-striatal dopamine receptors studied with [125I]epideprideIn VITRO and [[11C]FLB 457in vivo Pharmacological Research. 31: 29-29. DOI: 10.1016/1043-6618(95)86377-X |
0.544 |
|
| 1995 |
Hall H, Halldin C, Suzuki M, Dijkstra D, Wikström H, Wise L, Pugsley T, Hurd Y, Farde L, Pauli S, Sedvall G. P-4-61 Autoradiographic comparison of D2- and D3-dopamine receptor localization in the post mortem human brain using [125I]epidepride and [3H]PD 128907 European Neuropsychopharmacology. 5: 346. DOI: 10.1016/0924-977X(95)90581-W |
0.577 |
|
| 1995 |
Karlsson P, Farde L, Halldin C, Sedvall G. Decreased D1-dopamine receptor binding in drug naive schizophrenic patients examined by pet Schizophrenia Research. 15: 86. DOI: 10.1016/0920-9964(95)95267-D |
0.619 |
|
| 1995 |
Farde L, Nordstrom AL, Karlsson P, Halldin C, Sedvall G, Sethy, Schwartz JC, Von Voigtlander. Positron emission tomography studies on dopamine receptors in schizophrenia Clinical Neuropharmacology. 18: S121-S129. |
0.329 |
|
| 1994 |
Sedvall G, Karlsson P, Lundin A, Anvret M, Suhara T, Halldin C, Farde L. Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease. European Archives of Psychiatry and Clinical Neuroscience. 243: 249-55. PMID 8172940 DOI: 10.1007/Bf02191583 |
0.633 |
|
| 1994 |
Brené S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 985-98. PMID 8120638 DOI: 10.1523/Jneurosci.14-03-00985.1994 |
0.327 |
|
| 1994 |
Farde L, Pauli S, Litton JE, Halldin C, Neiman J, Sedvall G. PET-determination of benzodiazepine receptor binding in studies on alcoholism. Exs. 71: 143-53. PMID 8032146 |
0.479 |
|
| 1994 |
Farde L, Nordström AL, Nyberg S, Halldin C, Sedvall G. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients. The Journal of Clinical Psychiatry. 55: 67-9. PMID 7961577 |
0.535 |
|
| 1994 |
Sedvall G. [Image processing in psychiatry--a review]. Fortschritte Der Neurologie-Psychiatrie. 62: 39-43. PMID 7959526 |
0.366 |
|
| 1994 |
Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 11: 245-56. PMID 7531978 DOI: 10.1038/Sj.Npp.1380111 |
0.637 |
|
| 1994 |
Swahn C, Halldin C, Farde L, Sedvall G. Metabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC Human Psychopharmacology: Clinical and Experimental. 9: 25-31. DOI: 10.1002/Hup.470090103 |
0.503 |
|
| 1994 |
Swahn CG, Halldin C, Farde L, Karlsson P, Sedvall G. Metabolism in human plasma determined by HPLC for five 11C-labelled benzazepines-radioligands for PET examination of the dopamine D-1 receptor Journal of Labelled Compounds and Radiopharmaceuticals. 35: 540-542. |
0.358 |
|
| 1994 |
Halidin C, Swahn CG, Suhara T, Farde L, Karlsson P, Sokoloff P, Sedvall G. Preparation of (+)-[propyl-11C]7-OH-DPAT, a selective dopamine D-3 receptor agonist for PET Journal of Labelled Compounds and Radiopharmaceuticals. 35: 471-472. |
0.383 |
|
| 1993 |
Jönsson E, Lannfelt L, Sokoloff P, Schwartz JC, Sedvall G. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatrica Scandinavica. 87: 345-9. PMID 8517175 DOI: 10.1111/J.1600-0447.1993.Tb03384.X |
0.447 |
|
| 1993 |
Hall H, Halldin C, Sedvall G. Binding of [3H]SCH 39166 to human post mortem brain tissue. Pharmacology & Toxicology. 72: 152-8. PMID 8516265 DOI: 10.1111/J.1600-0773.1993.Tb00308.X |
0.393 |
|
| 1993 |
Litton JE, Neiman J, Pauli S, Farde L, Hindmarsh T, Halldin C, Sedvall G. PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls. Psychiatry Research. 50: 1-13. PMID 8390063 DOI: 10.1016/0925-4927(93)90019-E |
0.541 |
|
| 1993 |
Halldin C, Foged C, Farde L, Karlsson P, Hansen K, Grønvald F, Swahn CG, Hall H, Sedvall G. [11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey. Nuclear Medicine and Biology. 20: 945-53. PMID 8298574 DOI: 10.1016/0969-8051(93)90095-C |
0.607 |
|
| 1993 |
Karlsson P, Farde L, Halldin C, Swahn CG, Sedvall G, Foged C, Hansen KT, Skrumsager B. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology. 113: 149-56. PMID 7855175 DOI: 10.1007/Bf02245691 |
0.622 |
|
| 1992 |
Hall H, Halldin C, Sedvall G. Gpp(NH)p stimulates [3H]raclopride binding to homogenates from human putamen and accumbens. Neuroscience Letters. 136: 79-82. PMID 1635671 DOI: 10.1016/0304-3940(92)90652-N |
0.445 |
|
| 1992 |
Kopp J, Lindefors N, Brené S, Hall H, Persson H, Sedvall G. Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain. Neuroscience. 47: 771-9. PMID 1533704 DOI: 10.1016/0306-4522(92)90028-Z |
0.483 |
|
| 1992 |
Sedvall G. The current status of PET scanning with respect to schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 7: 41-54. PMID 1388021 |
0.411 |
|
| 1992 |
Hall H, Farde L, Halldin C, Högberg T, Larsson S, Sedvall G. Imaging of dopamine receptors using PET and SPECT. Neurochemistry International. 20: 329S-333S. PMID 1365450 DOI: 10.1016/0197-0186(92)90260-X |
0.578 |
|
| 1992 |
Farde L, Nordström AL, Halldin C, Wiesel FA, Sedvall G. PET studies of dopamine receptors in relation to antipsychotic drug treatment. Clinical Neuropharmacology. 15: 468A-469A. PMID 1354052 |
0.532 |
|
| 1992 |
Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Archives of General Psychiatry. 49: 538-44. PMID 1352677 DOI: 10.1001/Archpsyc.1992.01820070032005 |
0.558 |
|
| 1992 |
Halldin C, Farde L, Litton JE, Hall H, Sedvall G. [11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomography. Psychopharmacology. 108: 16-22. PMID 1329130 DOI: 10.1007/Bf02245279 |
0.576 |
|
| 1992 |
Pauli S, Liljequist S, Farde L, Swahn CG, Halldin C, Litton JE, Sedvall G. PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil. Psychopharmacology. 107: 180-5. PMID 1319600 DOI: 10.1007/Bf02245135 |
0.529 |
|
| 1992 |
Lannfelt L, Sokoloff P, Martres M, Pilon C, Giros B, Jönsson E, Sedvall G, Schwartz J. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders Psychiatric Genetics. 2: 249-256. DOI: 10.1097/00041444-199210000-00003 |
0.478 |
|
| 1992 |
SEDVALL G, FARDE L, NORDSTROM A. PET SCANNING OF DOPAMINE RECEPTORS AND PSYCHOSIS Behavioural Pharmacology. 3: 21. DOI: 10.1097/00008877-199204001-00061 |
0.602 |
|
| 1992 |
Lindefors N, Brené S, Kopp J, Hall H, Persson H, Sedvall G. NEUROLEPTIC TREATMENT AND DOPAMINE LESIONS MODULATE POST-SYNAPTIC EXPRESSION OF DOPAMINE D2 RECEPTOR mRNA IN RAT BRAIN. Clinical Neuropharmacology. 15: 131B. DOI: 10.1097/00002826-199202001-00251 |
0.429 |
|
| 1992 |
Hall H, Farde L, Litton JE, Halldin C, Sedvall G. PET AND AUTORADIOGRAPHY OF BENZODIAZEPINE RECEPTOR BINDING WITH RADIOLABELLED FLUMAZENIL AND RO 15-4513. Clinical Neuropharmacology. 15: 29B. DOI: 10.1097/00002826-199202001-00054 |
0.549 |
|
| 1992 |
Swahn CG, Farde L, Halldin C, Sedvall G. Ligand metabolites in plasma during PET-studies with the 11C-labelled dopamine antagonists, raclopride, SCH 23390 and N-methylspiroperidol Human Psychopharmacology. 7: 97-103. DOI: 10.1002/Hup.470070204 |
0.511 |
|
| 1991 |
Persson A, d'Argy R, Gillberg PG, Halldin C, Litton JE, Swahn CG, Sedvall G. Autoradiography with saturation experiments of 11C-Ro 15-1788 binding to human brain sections. Journal of Neuroscience Methods. 36: 53-61. PMID 2062111 DOI: 10.1016/0165-0270(91)90137-O |
0.387 |
|
| 1991 |
Sedvall G, Farde L, Barnett A, Hall H, Halldin C. 11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET. Psychopharmacology. 103: 150-3. PMID 1674157 DOI: 10.1007/Bf02244195 |
0.648 |
|
| 1991 |
Halldin C, Farde L, Hall H, Högberg T, Printz G, Pulka W, Sedvall G, Solin O. Synthesis of five benzamide analogs. Comparison with positron emission tomography. Acta Radiologica. Supplementum. 376: 121-2. PMID 1666743 |
0.379 |
|
| 1991 |
Halldin C, Farde L, Barnett A, Sedvall G. Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 42: 451-5. PMID 1646191 DOI: 10.1016/0883-2889(91)90105-A |
0.605 |
|
| 1991 |
Pauli S, Farde L, Halldin C, Sedvall G. Occupancy of the central benzodiazepine receptors during benzodiazepine treatment determined by PET European Neuropsychopharmacology. 1: 229-231. DOI: 10.1016/0924-977X(91)90498-J |
0.54 |
|
| 1991 |
Halldin C, Farde L, Barnett A, Sedvall G. Synthesis of [11C]SCH 39166, a new selective D-1 dopamine receptor ligand for PET Journal of Labelled Compounds and Radiopharmaceuticals. 30: 349 -350. |
0.364 |
|
| 1990 |
Halldin C, Farde L, Högberg T, Hall H, Sedvall G. Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 41: 669-74. PMID 2170298 DOI: 10.1016/0883-2889(90)90082-R |
0.586 |
|
| 1990 |
Kopp J, Hall H, Persson A, Sedvall G. Temperature dependence of [3H]Ro 15-1788 binding to benzodiazepine receptors in human postmortem brain homogenates. Journal of Neurochemistry. 55: 1310-5. PMID 2168936 DOI: 10.1111/J.1471-4159.1990.Tb03140.X |
0.356 |
|
| 1990 |
Wiesel FA, Farde L, Nordström AL, Sedvall G. Central D1- and D2-receptor occupancy during antipsychotic drug treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 14: 759-67. PMID 1981395 DOI: 10.1016/0278-5846(90)90046-J |
0.613 |
|
| 1990 |
Sedvall G. Monoamines and schizophrenia. Acta Psychiatrica Scandinavica. Supplementum. 358: 7-13. PMID 1978495 DOI: 10.1111/J.1600-0447.1990.Tb05279.X |
0.492 |
|
| 1990 |
Farde L, Wiesel FA, Stone-Elander S, Halldin C, Nordström AL, Hall H, Sedvall G. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Archives of General Psychiatry. 47: 213-9. PMID 1968328 DOI: 10.1001/Archpsyc.1990.01810150013003 |
0.647 |
|
| 1990 |
Sedvall G, Farde L, Nybäck H, Pauli S, Persson A, Savic I, Wiesel FA. Recent advances in psychiatric brain imaging. Acta Radiologica. Supplementum. 374: 113-5. PMID 1966956 |
0.428 |
|
| 1990 |
Sedvall G. PET imaging of dopamine receptors in human basal ganglia: relevance to mental illness. Trends in Neurosciences. 13: 302-8. PMID 1695408 DOI: 10.1016/0166-2236(90)90114-P |
0.43 |
|
| 1990 |
Farde L, Nordstrom A, Wiesel F, Halldin C, Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with classical and atypical neurpleptics Schizophrenia Research. 3: 51-52. DOI: 10.1016/0920-9964(90)90133-R |
0.582 |
|
| 1989 |
Farde L, Wiesel FA, Nilsson L, Sedvall G. The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics. Psychopharmacology Series. 7: 32-9. PMID 2574454 DOI: 10.1007/978-3-642-74430-3_4 |
0.403 |
|
| 1989 |
Sedvall G. Approaches for finding new types of antipsychotic compounds. Acta Psychiatrica Scandinavica. Supplementum. 352: 16-23. PMID 2573237 DOI: 10.1111/J.1600-0447.1989.Tb06431.X |
0.394 |
|
| 1989 |
Farde L, Wiesel FA, Nordström AL, Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology. 99: S28-31. PMID 2573104 DOI: 10.1007/BF00442555 |
0.614 |
|
| 1989 |
Walaas SI, Sedvall G, Greengard P. Dopamine-regulated phosphorylation of synaptic vesicle-associated proteins in rat neostriatum and substantia nigra. Neuroscience. 29: 9-19. PMID 2496331 DOI: 10.1016/0306-4522(89)90328-X |
0.365 |
|
| 1989 |
Persson A, Pauli S, Swahn CG, Halldin C, Sedvall G. Cerebral uptake of 11C—Ro 15—1788 and its acid metabolite 11C—Ro 15—3890; PET study in healthy volunteers Human Psychopharmacology-Clinical and Experimental. 4: 215-220. DOI: 10.1002/Hup.470040307 |
0.36 |
|
| 1989 |
Persson A, Pauli S, Halldin C, Stone-Elander S, Farde L, Sjögren I, Sedvall G. Saturation analysis of specific11C Ro 15-1788 binding to the human neocortex using positron emission tomography Human Psychopharmacology: Clinical and Experimental. 4: 21-31. DOI: 10.1002/Hup.470040105 |
0.583 |
|
| 1989 |
Farde L, Wiesel FA, Halldin C, Sedvall G, Nilsson L. Dopamine Receptor Occupancy and Plasma Haloperidol Levels-Reply Archives of General Psychiatry. 46: 483-484. DOI: 10.1001/Archpsyc.1989.01810050097022 |
0.575 |
|
| 1988 |
Farde L, Wiesel FA, Jansson P, Uppfeldt G, Wahlen A, Sedvall G. An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology. 94: 1-7. PMID 3126517 DOI: 10.1007/BF00735871 |
0.621 |
|
| 1988 |
Sedvall G, Farde L, Hall H, Pauli S, Persson A, Wiesel FA. PET scanning--a new tool in clinical psychopharmacology. Psychopharmacology Series. 5: 27-33. PMID 3045802 DOI: 10.1007/978-3-642-73280-5_3 |
0.65 |
|
| 1988 |
Hall H, Köhler C, Gawell L, Farde L, Sedvall G. Raclopride, a new selective ligand for the dopamine-D2 receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 559-68. PMID 2975809 DOI: 10.1016/0278-5846(88)90001-2 |
0.641 |
|
| 1988 |
Andreasen NC, Carson R, Diksic M, Evans A, Farde L, Gjedde A, Hakim A, Lal S, Nair N, Sedvall G. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Schizophrenia Bulletin. 14: 471-84. PMID 2975043 DOI: 10.1093/SCHBUL/14.3.471 |
0.592 |
|
| 1988 |
Hall H, Farde L, Sedvall G. Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride. Journal of Neural Transmission. 73: 7-21. PMID 2969950 DOI: 10.1007/BF01244618 |
0.632 |
|
| 1988 |
Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widén L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet (London, England). 2: 863-6. PMID 2902315 DOI: 10.1016/S0140-6736(88)92468-3 |
0.431 |
|
| 1988 |
Farde L, Grind M, Nilsson MI, Ogenstad S, Sedvall G. Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers. Psychopharmacology. 95: 157-61. PMID 2901121 DOI: 10.1007/BF00174501 |
0.458 |
|
| 1988 |
Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Archives of General Psychiatry. 45: 71-6. PMID 2892477 DOI: 10.1001/Archpsyc.1988.01800250087012 |
0.609 |
|
| 1987 |
Lindvall O, Backlund EO, Farde L, Sedvall G, Freedman R, Hoffer B, Nobin A, Seiger A, Olson L. Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Annals of Neurology. 22: 457-68. PMID 3435067 DOI: 10.1002/Ana.410220403 |
0.464 |
|
| 1987 |
d'Argy R, Persson A, Sedvall G. A quantitative cerebral and whole body autoradiographic study of a intravenously administered benzodiazepine antagonist 3H-Ro 15-1788 in mice. Psychopharmacology. 92: 8-13. PMID 3037585 DOI: 10.1007/BF00215472 |
0.337 |
|
| 1987 |
Farde L, Halldin C, Stone-Elander S, Sedvall G. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. Psychopharmacology. 92: 278-84. PMID 2957716 DOI: 10.1007/Bf00210831 |
0.638 |
|
| 1987 |
Sedvall G, Farde L, Wiesel FA. Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients. Life Sciences. 41: 813-6. PMID 2956473 DOI: 10.1016/0024-3205(87)90169-X |
0.598 |
|
| 1987 |
Farde L, Wiesel FA, Hall H, Halldin C, Stone-Elander S, Sedvall G. No D2 receptor increase in PET study of schizophrenia. Archives of General Psychiatry. 44: 671-2. PMID 2955770 DOI: 10.1001/Archpsyc.1987.01800190091013 |
0.61 |
|
| 1987 |
Sedvall G, Nybäck H, Farde L, Persson A. Neurotransmitter receptor imaging in Alzheimer's disease. Journal of Neural Transmission. Supplementum. 24: 43-8. PMID 2824693 |
0.35 |
|
| 1987 |
Sedvall G, Ehrin E, Farde L. Stereoselective binding of11C-labelled piquindone (Ro 22-1319) to dopamine-D2 receptors in the living human brain Human Psychopharmacology: Clinical and Experimental. 2: 23-30. DOI: 10.1002/HUP.470020105 |
0.649 |
|
| 1986 |
Nock B, Sedvall G, Mcewen BS. Quantitative autoradiography of [3H]piquindone binding sites (dopamine D2 receptors) in rat brain. European Journal of Pharmacology. 121: 387-93. PMID 3699100 DOI: 10.1016/0014-2999(86)90259-1 |
0.413 |
|
| 1986 |
Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, Långström B, Sedvall G. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 1039-43. PMID 3027000 DOI: 10.1016/0883-2889(86)90044-4 |
0.591 |
|
| 1986 |
Sedvall G, Farde L, Persson A, Wiesel FA. Imaging of neurotransmitter receptors in the living human brain. Archives of General Psychiatry. 43: 995-1005. PMID 3019270 DOI: 10.1001/Archpsyc.1986.01800100089012 |
0.534 |
|
| 1986 |
Sedvall G, Farde L, Stone-Elander S, Halldin C. Dopamine D1-receptor binding in the living human brain. Advances in Experimental Medicine and Biology. 204: 119-24. PMID 2947423 DOI: 10.1007/978-1-4684-5191-7_7 |
0.631 |
|
| 1986 |
Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science (New York, N.Y.). 231: 258-61. PMID 2867601 DOI: 10.1126/SCIENCE.2867601 |
0.643 |
|
| 1985 |
Ehrin E, Farde L, de Paulis T, Eriksson L, Greitz T, Johnström P, Litton JE, Nilsson JL, Sedvall G, Stone-Elander S. Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. The International Journal of Applied Radiation and Isotopes. 36: 269-73. PMID 3874833 DOI: 10.1016/0020-708X(85)90083-3 |
0.619 |
|
| 1985 |
Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström CG, Litton JE, Sedvall G. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 82: 3863-7. PMID 3873656 DOI: 10.1073/PNAS.82.11.3863 |
0.632 |
|
| 1985 |
Persson A, Ehrin E, Eriksson L, Farde L, Hedström CG, Litton JE, Mindus P, Sedvall G. Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. Journal of Psychiatric Research. 19: 609-22. PMID 3001301 DOI: 10.1016/0022-3956(85)90080-9 |
0.578 |
|
| 1985 |
Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA. Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. The British Journal of Psychiatry : the Journal of Mental Science. 147: 276-82. PMID 2415198 DOI: 10.1192/Bjp.147.3.276 |
0.356 |
|
| 1984 |
Oxenstierna G, Bergstrand G, Bjerkenstedt L, Sedvall G, Wik G. Evidence of disturbed CSF circulation and brain atrophy in cases of schizophrenic psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 144: 654-61. PMID 6743934 DOI: 10.1192/Bjp.144.6.654 |
0.308 |
|
| 1984 |
Widén L, Blomqvist G, DePaulis T, Ehrin E, Eriksson L, Farde L, Greitz T, Hedström CG, Ingvar DH, Litton JE, Nilsson JL, Ögren SO, Sedvall G, Stone-Slander S, Wiesel F-, et al. STUDIES OF SCHIZOPHRENIA WITH POSITRON CT Clinical Neuropharmacology. 7: S295. DOI: 10.1097/00002826-198406001-00266 |
0.466 |
|
| 1983 |
Nybäck H, Berggren BM, Hindmarsh T, Sedvall G, Wiesel FA. Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Research. 9: 301-8. PMID 6196802 DOI: 10.1016/0165-1781(83)90003-3 |
0.322 |
|
| 1983 |
Borg S, Kvande H, Sedvall G. Monoamine Metabolites In Lumbar Cerebrospinal Fluid And Urine In Alcoholic Patients Before And After Treatment With Disulfiram Alcohol and Alcoholism. 18: 61-65. DOI: 10.1093/Oxfordjournals.Alcalc.A044338 |
0.322 |
|
| 1982 |
Wiesel FA, Alfredsson G, Ehrnebo M, Sedvall G. Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations. Psychopharmacology. 76: 44-7. PMID 6805007 DOI: 10.1007/Bf00430753 |
0.32 |
|
| 1978 |
Lindholm H, Gullberg B, Ohman A, Sedvall G. Effects of perphenazine enanthate injections on prolactin levels in plasma from schizophrenic women and men. Psychopharmacology. 57: 1-4. PMID 96459 DOI: 10.1007/Bf00426949 |
0.302 |
|
| 1978 |
Sedvall G, Bjerkenstedt L, Lindström L, Wode-Helgodt B. Clinical assessment of dopamine receptor blockade. Life Sciences. 23: 425-9. PMID 29184 DOI: 10.1016/0024-3205(78)90147-9 |
0.422 |
|
| 1977 |
Wode-Helgodt B, Fyrö B, Gullberg B, Sedvall G. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients. Acta Psychiatrica Scandinavica. 56: 129-42. PMID 899844 DOI: 10.1111/J.1600-0447.1977.Tb06671.X |
0.334 |
|
| 1977 |
Bjerkenstedt L, Gullberg B, Härnryd C, Sedvall G. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene. Archiv Fã¼R Psychiatrie Und Nervenkrankheiten. 224: 107-18. PMID 21644 DOI: 10.1007/Bf00346479 |
0.367 |
|
| 1976 |
Swahn C-G, Sandgárde B, Wiesel F-A, Sedvall G. Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology. 48: 147-53. PMID 826926 DOI: 10.1007/Bf00423253 |
0.306 |
|
| 1976 |
Nyback H, Sedvall G. Effects of neuroleptics on striatal dopamine synthesized from 14C-tyrosine. Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology. 2: 49-63. PMID 772722 DOI: 10.1016/0306-039X(76)90018-0 |
0.397 |
|
| 1975 |
Sedvall G. A relation between drug concentrations in brain and striatal homovanillic acid levels in chlorpromazine treated rats. Life Sciences. 16: 1145-55. PMID 1134188 DOI: 10.1016/0024-3205(75)90198-8 |
0.315 |
|
| 1975 |
Wiesel FA, Sedvall G. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat. European Journal of Pharmacology. 30: 364-7. PMID 236193 DOI: 10.1016/0014-2999(75)90123-5 |
0.314 |
|
| 1974 |
Fyrö B, Wode-Helgodt B, Borg S, Sedvall G. The effect of chlorpromazine on homovanillic acid levels in cerebrospinal fluid of schizophrenic patients. Psychopharmacologia. 35: 287-94. PMID 4831513 DOI: 10.1007/Bf00429219 |
0.36 |
|
| 1974 |
Sedvall G, Fyrö B, Nybäck H, Wiesel FA, Wode-Helgodt B. Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs. Journal of Psychiatric Research. 11: 75-80. PMID 4461807 DOI: 10.1016/0022-3956(74)90075-2 |
0.453 |
|
| 1974 |
Wiesel FA, Sedvall G. Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass fragmentography. Brain Research. 65: 547-50. PMID 4415145 DOI: 10.1016/0006-8993(74)90247-9 |
0.328 |
|
| 1973 |
Wiesel FA, Fri CG, Sedvall G. Determination of homovanillic acid turnover in rat striatum using a monoamine oxidase inhibitor. European Journal of Pharmacology. 23: 104-6. PMID 4733765 DOI: 10.1016/0014-2999(73)90250-1 |
0.313 |
|
| 1973 |
Mayevsky A, Sjöquist B, Fri CG, Samuel D, Sedvall G. Incorporation of 18 O into homovanillic acid of rat brain during exposure to oxygen 18 containing atmospheres. Biochemical and Biophysical Research Communications. 51: 746-55. PMID 4704058 DOI: 10.1016/0006-291X(73)91379-X |
0.306 |
|
| 1973 |
Sjöquist B, Dailey J, Sedvall G, Anggård E. Mass fragmentographic assay of homovanillic acid in brain tissue. Journal of Neurochemistry. 20: 729-33. PMID 4703787 DOI: 10.1111/j.1471-4159.1973.tb00033.x |
0.34 |
|
| 1972 |
Nybäck H, Sedvall G. Effect of chlorpromazine and some of its metabolites on synthesis and turnover of catecholamines formed from 14 C-tyrosine in mouse brain. Psychopharmacologia. 26: 155-60. PMID 5073041 DOI: 10.1007/Bf00422102 |
0.454 |
|
| 1972 |
Fyrö B, Nybäck H, Sedvall G. Tyrosine hydroxylation in the rat striatum in vitro and in vivo after nigral lesion and chlorpromazine treatment. Neuropharmacology. 11: 531-7. PMID 4403078 DOI: 10.1016/0028-3908(72)90008-1 |
0.385 |
|
| 1972 |
Schubert J, Sedvall G. Effect of amphetamines on tryptophan concentrations in mice and rats. The Journal of Pharmacy and Pharmacology. 24: 53-62. PMID 4401317 DOI: 10.1111/J.2042-7158.1972.Tb08864.X |
0.308 |
|
| 1971 |
Nybäck H, Sedvall G. Effect of nigral lesion on chlorpromazine-induced acceleration of dopamine synthesis from [14C]tyrosine. Journal of Pharmacy and Pharmacology. 23: 322-326. PMID 4397399 DOI: 10.1111/J.2042-7158.1971.Tb09921.X |
0.396 |
|
| 1970 |
Nybäck H, Sedvall G. Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues. European Journal of Pharmacology. 10: 193-205. PMID 5446375 DOI: 10.1016/0014-2999(70)90273-6 |
0.391 |
|
| 1970 |
Nybäck H, Schubert J, Sedvall G. Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain. The Journal of Pharmacy and Pharmacology. 22: 622-4. PMID 4394540 DOI: 10.1111/J.2042-7158.1970.Tb10583.X |
0.328 |
|
| 1969 |
Nybäck H, Sedvall G. Regional accumulation of catecholamines formed from tyrosine-14C in rat brain: effect of chlorpromazine. European Journal of Pharmacology. 5: 245-52. PMID 5772674 DOI: 10.1016/0014-2999(69)90145-9 |
0.42 |
|
| 1968 |
Nybäck H, Borzecki Z, Sedvall G. Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs. European Journal of Pharmacology. 4: 395-403. PMID 5724916 DOI: 10.1016/0014-2999(68)90025-3 |
0.403 |
|
| 1967 |
Ngai SH, Rosell S, Sedvall G. Influence of hypercapnia on the noradrenalin content of sympathetically decentralized and innervated skeletal muscle. Experientia. 23: 394-5. PMID 6065787 |
0.401 |
|
| 1966 |
Fredholm B, Sedvall G. Influence of sympathetic nerve stimulation on noradrenaline stores in the rat salivary gland Life Sciences. 5: 2023-2032. DOI: 10.1016/0024-3205(66)90275-X |
0.435 |
|
| 1963 |
ROSELL S, SEDVALL G, ULLBERG S. Distribution and fate of dihydroxyphenylalanine-2-14C (DOPA) in mice. Biochemical Pharmacology. 12: 265-9. PMID 13974812 DOI: 10.1016/0006-2952(63)90149-7 |
0.565 |
|
| 1962 |
ROSELL S, SEDVALL G. The rate of disappearance of vasoconstrictor responses to sympathetic chain stimulation after reserpine treatment. Acta Physiologica Scandinavica. 56: 306-14. PMID 13974811 DOI: 10.1111/j.1748-1716.1962.tb02507.x |
0.481 |
|
| 1961 |
ROSELL S, SEDVALL G. Restoration of vasoconstrictor effects in reserpinized cats. Acta Physiologica Scandinavica. 53: 174-84. PMID 14493858 DOI: 10.1111/j.1748-1716.1961.tb02275.x |
0.567 |
|
| 1961 |
Rosell S, Sedvall G. 205 Quantitative aspects of the restoration of vasoconstrictor effects in reserpinized cats Biochemical Pharmacology. 8: 63-64. DOI: 10.1016/0006-2952(61)90383-5 |
0.417 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1980 |
Mathé AA, Sedvall G, Wiesel FA, Nybäck H. Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia. Lancet. 1: 16-8. PMID 6101355 DOI: 10.1016/S0140-6736(80)90553-X |
0.298 |
|
| 2001 |
Vawter MP, Usen N, Thatcher L, Ladenheim B, Zhang P, VanderPutten DM, Conant K, Herman MM, van Kammen DP, Sedvall G, Garver DL, Freed WJ. Characterization of human cleaved N-CAM and association with schizophrenia. Experimental Neurology. 172: 29-46. PMID 11681838 DOI: 10.1006/exnr.2001.7790 |
0.298 |
|
| 1970 |
Schubert J, Nybäck H, Sedvall G. Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain. The Journal of Pharmacy and Pharmacology. 22: 136-9. PMID 4392252 DOI: 10.1111/J.2042-7158.1970.Tb08410.X |
0.298 |
|
| 1973 |
Sedvall G, Nybäck H. Effect of clozapine and some other antipsychotic agents on synthesis and turnover of dopamine formed from 14C-tyrosine in mouse brain. Israel Journal of Medical Sciences. 9: 24-30. PMID 10189869 |
0.297 |
|
| 1994 |
Geijer T, Neiman J, Rydberg U, Gyllander A, Jönsson E, Sedvall G, Valverius P, Terenius L. Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics. European Archives of Psychiatry and Clinical Neuroscience. 244: 26-32. PMID 7918698 DOI: 10.1007/BF02279808 |
0.296 |
|
| 1988 |
Swahn CG, Sedvall G. CSF creatinine in schizophrenia. Biological Psychiatry. 23: 586-94. PMID 2451543 DOI: 10.1016/0006-3223(88)90005-4 |
0.294 |
|
| 1967 |
Nybäck H, Sedvall G. The effect of chlorpromazine on catecholamine synthesis in rat and mouse brain. Acta Pharmacologica Et Toxicologica. 25: Suppl 4:23-4. PMID 5630930 DOI: 10.1111/J.1600-0773.1967.Tb03014.X |
0.292 |
|
| 1980 |
Alfredsson G, Sedvall G. Protein binding of chlorpromazine in cerebrospinal fluid and serum. International Pharmacopsychiatry. 15: 261-9. PMID 7263148 DOI: 10.1159/000468449 |
0.292 |
|
| 1989 |
Halldin C, Stone-Elander S, Thorell J, Persson A, Sedvall G. 11C-labelling of the benzodiazepine antagonist RO 15-1788, in two different positions, and its main metabolite RO 15-3890 Journal of Labelled Compounds and Radiopharmaceuticals. 26: 375-377. DOI: 10.1002/Jlcr.25802601161 |
0.29 |
|
| 1989 |
Brené S, Lindefors N, Kopp J, Sedvall G, Persson H. Regional distribution of neuropeptide Y mRNA in postmortem human brain. Brain Research. Molecular Brain Research. 6: 241-9. PMID 2593779 DOI: 10.1016/0169-328X(89)90070-3 |
0.29 |
|
| 1977 |
Beck O, Wiesel FA, Sedvall G. Mass fragmentographic determination of 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid in brain tissue using deuterated internal standards. Journal of Chromatography. 134: 407-14. PMID 140179 DOI: 10.1016/S0021-9673(00)88539-8 |
0.286 |
|
| 1997 |
JÅnsson E, Brené S, Zhang XR, Nimgaonkar VL, Tylec A, Schalling M, Sedvall G. Schizophrenia and neurotrophin-3 alleles. Acta Psychiatrica Scandinavica. 95: 414-9. PMID 9197906 DOI: 10.1111/J.1600-0447.1997.Tb09654.X |
0.285 |
|
| 1992 |
Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jönsson E, Sedvall G, Schwartz JC. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders Psychiatric Genetics. 2: 249-256. |
0.284 |
|
| 1988 |
Halldin C, Stone-Elander S, Thorell JO, Persson A, Sedvall G. 11C-labelling of Ro 15-1788 in two different positions, and also 11C-labelling of its main metabolite Ro 15-3890, for PET studies of benzodiazepine receptors. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 39: 993-7. PMID 2848785 DOI: 10.1016/0883-2889(88)90044-5 |
0.284 |
|
| 1974 |
Wiesel FA, Fri CG, Sedvall G. Simultaneous mass fragmentographic determination of 3, 4-dihydroxyphenylacetic acid and 4 hydroxy-3-methoxyphenylacetic acid in brain tissue. Journal of Neural Transmission. 35: 319-26. PMID 4436671 DOI: 10.1007/Bf02205228 |
0.283 |
|
| 1970 |
Schubert J, Fyrö B, Nybäck H, Sedvall G. Effects of cocaine and amphetamine on the metabolism of tryptophan and 5-hydroxytryptamine in mouse brain in vivo. The Journal of Pharmacy and Pharmacology. 22: 860-2. PMID 4395808 DOI: 10.1111/J.2042-7158.1970.Tb08457.X |
0.283 |
|
| 1970 |
Schubert J, Nybäck H, Sedvall G. Accumulation and disappearance of 3H-5-hydroxytryptamine formed from 3H-tryptophan in mouse brain; effect of LSD-25. European Journal of Pharmacology. 10: 215-24. PMID 5446376 DOI: 10.1016/0014-2999(70)90275-X |
0.282 |
|
| 1989 |
Köhler C, Persson A, Melander T, Theodorsson E, Sedvall G, Hökfelt T. Distribution of galanin-binding sites in the monkey and human telencephalon: preliminary observations. Experimental Brain Research. 75: 375-80. PMID 2721615 DOI: 10.1007/BF00247944 |
0.282 |
|
| 1970 |
Anggård E, Sedvall G, Sjöquist B. Chromatography of biogenic amine metabolites and related compounds on lipophilic sephadex. II. The catecholamines and their 3-O-methylated derivatives. Journal of Chromatography. 52: 87-96. PMID 5474898 DOI: 10.1016/S0021-9673(01)96547-1 |
0.281 |
|
| 1979 |
Härnryd C, Bjerkenstedt L, Grimm VE, Sedvall G. Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment. Psychopharmacology. 64: 131-4. PMID 115032 DOI: 10.1007/Bf00496052 |
0.28 |
|
| 1986 |
Bergstrand G, Oxenstierna G, Flyckt L, Larsson SA, Sedvall G. Radionuclide cisternography and computed tomography in 30 healthy volunteers. Neuroradiology. 28: 154-60. PMID 3517686 DOI: 10.1007/Bf00327889 |
0.278 |
|
| 1972 |
Schubert J, Sedvall G. Accumulation and disappearance of 3 H-5-hydroxytryptamine formed in vivo from 3 H-tryptophan in various regions of the rat brain. European Journal of Pharmacology. 17: 75-80. PMID 5016584 DOI: 10.1016/0014-2999(72)90271-3 |
0.278 |
|
| 1972 |
Dailey J, Sedvall G, Sjöquist B. Effect of chlorpromazine and some of its metabolites on the accumulation of homovanilic acid in brain of mice. The Journal of Pharmacy and Pharmacology. 24: 580-1. PMID 4403854 DOI: 10.1111/j.2042-7158.1972.tb09062.x |
0.278 |
|
| 1985 |
Backlund EO, Granberg PO, Hamberger B, Knutsson E, MÃ¥rtensson A, Sedvall G, Seiger A, Olson L. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. Journal of Neurosurgery. 62: 169-73. PMID 2578558 DOI: 10.3171/jns.1985.62.2.0169 |
0.278 |
|
| 2012 |
Andreou D, Saetre P, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. European Archives of Psychiatry and Clinical Neuroscience. 262: 549-56. PMID 22454242 DOI: 10.1007/s00406-012-0313-z |
0.277 |
|
| 1975 |
Fyrö B, Petterson U, Sedvall G. The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients. Psychopharmacologia. 44: 99-103. PMID 1105629 DOI: 10.1007/Bf00421192 |
0.277 |
|
| 1979 |
Bjerkenstedt L, Gullberg B, Härnryd C, Sedvall G. Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women. Archiv Fã¼R Psychiatrie Und Nervenkrankheiten. 227: 181-92. PMID 94992 DOI: 10.1007/Bf00367389 |
0.276 |
|
| 2001 |
Agartz I, Okuguwa G, Nordström M, Greitz D, Magnotta V, Sedvall G. Reliability and reproducibility of brain tissue volumetry from segmented MR scans. European Archives of Psychiatry and Clinical Neuroscience. 251: 255-61. PMID 11881838 DOI: 10.1007/Pl00007542 |
0.276 |
|
| 1991 |
Lindefors N, Brené S, Kopp J, Lindén A, Brodin E, Sedvall G, Persson H. Distribution of cholecystokinin mRNA and peptides in the human brain. Neuroscience. 42: 813-21. PMID 1956517 DOI: 10.1016/0306-4522(91)90046-Q |
0.275 |
|
| 2016 |
Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG. Associations between a locus downstream DRD1 gene and cerebrospinal fluid dopamine metabolite concentrations in psychosis. Neuroscience Letters. PMID 26957229 DOI: 10.1016/j.neulet.2016.03.005 |
0.274 |
|
| 1979 |
Alfredsson G, Sedvall G, Wiesel FA. Quantitative analysis of sulpiride in body fluids by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography. 164: 187-93. PMID 541409 DOI: 10.1016/S0378-4347(00)81187-1 |
0.274 |
|
| 1966 |
Strandberg K, Sedvall G, Midtvedt T, Gustafsson B. Effect of some biologically active amines on the cecum wall of germfree rats. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 121: 699-702. PMID 5935571 DOI: 10.3181/00379727-121-30864 |
0.273 |
|
| 1984 |
Beck O, Borg S, Edman G, Fyrö B, Oxenstierna G, Sedvall G. 5-hydroxytryptophol in human cerebrospinal fluid: conjugation, concentration gradient, relationship to 5-hydroxyindoleacetic acid, and influence of hereditary factors. Journal of Neurochemistry. 43: 58-61. PMID 6202846 DOI: 10.1111/J.1471-4159.1984.Tb06678.X |
0.273 |
|
| 2002 |
Okugawa G, Sedvall G, Agartz I. Cerebellar vermis volume reduction in patients with chronic schizophrenia European Psychiatry. 17: 111. DOI: 10.1016/S0924-9338(02)80497-7 |
0.273 |
|
| 1983 |
Widén L, Bergström M, Blomqvist G, Brismar T, Ehrin E, Ericson K, Eriksson L, Greitz T, Ingvar DH, Johansson L, Litton J, Printz G, Nilsson JLG, Sedvall G, Stone-Elander S, et al. PET MEASUREMENTS OF GLUCOSE METABOLISM, USING 11C-GLUCOSE IN PATIENTS WITH SCHIZOPHRENIA Journal of Computer Assisted Tomography. 7: 186. DOI: 10.1097/00004728-198302000-00085 |
0.272 |
|
| 1978 |
Wode-Helgodt B, Borg S, Fyrö B, Sedvall G. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine. Acta Psychiatrica Scandinavica. 58: 149-73. PMID 358755 DOI: 10.1111/J.1600-0447.1978.Tb06929.X |
0.272 |
|
| 1986 |
Wik G, Wiesel FA, Eneroth P, Sedvall G, Aström G. Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment. Acta Psychiatrica Scandinavica. 74: 161-7. PMID 2877544 DOI: 10.1111/J.1600-0447.1986.Tb10600.X |
0.271 |
|
| 1997 |
Jönsson EG, Nöthen MM, Gustavsson JP, Neidt H, Brené S, Tylec A, Propping P, Sedvall GC. Lack of evidence for allelic association between personality traits and the dopamine D4 receptor gene polymorphisms. The American Journal of Psychiatry. 154: 697-9. PMID 9137132 |
0.271 |
|
| 1975 |
Fyrö B, Settergren G, Sedvall G. Release of homovanillic acid from the brain of children. Life Sciences. 17: 397-402. PMID 1160509 DOI: 10.1016/0024-3205(75)90489-0 |
0.271 |
|
| 1992 |
Lindefors N, Brené S, Kopp J, Ehrlich M, Greengard P, Hall H, Sedvall G, Persson H. EXPRESSION OF mRNAs ENCODING THE PHOSPHOPROTEINS ARPP-16/19, ARPP-21 AND DARPP-32 IN THE HUMAN BRAIN Clinical Neuropharmacology. 15: 131B. DOI: 10.1097/00002826-199202001-00252 |
0.269 |
|
| 1977 |
Bjerkenstedt L, Eneroth P, Härnryd C, Sedvall G. Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women. Archiv Fã¼R Psychiatrie Und Nervenkrankheiten. 224: 281-93. PMID 343747 DOI: 10.1007/Bf00341611 |
0.266 |
|
| 1974 |
Fri CG, Wiesel FA, Sedvall G. Mass fragmentographic analysis of homovanillic acid and its homoiso analogue in cerebrospinal fluid using the alpha-dideutero acid as internal standard. Psychopharmacologia. 35: 295-304. PMID 4831514 DOI: 10.1007/Bf00429220 |
0.266 |
|
| 1983 |
Borg S, Kvande H, Mossberg D, Sedvall G. Central Nervous Noradrenaline Metabolism In Alcoholics During Long-Term Abstinence Alcohol and Alcoholism. 18: 321-323. DOI: 10.1093/Oxfordjournals.Alcalc.A044384 |
0.266 |
|
| 1996 |
Dean CE, Nordstrom AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. Unique receptor-blockading profile of clozapine [15] American Journal of Psychiatry. 153: 1239-1240. PMID 8780446 DOI: 10.1176/ajp.153.9.1239b |
0.264 |
|
| 1999 |
Arrang J-, Morisset S, Ito C, Tardivel-Lacombe J, Krebs M-, Olié J-, Lôo H, Poirier M-, Jönsson E, Sedvall G, Crocq M-, Sokoloff P, Schwartz J-. Potential role of histamine in schizophrenia European Neuropsychopharmacology. 9: 174-175. DOI: 10.1016/S0924-977X(99)80065-0 |
0.264 |
|
| 1986 |
Mindus P, Ehrin E, Ericsson L, Farde L, Hedström C, Litton J, Persson A, Sedvall G. Central Benzodiazepine Receptor Binding Studied with 11-C Labelled Ro 15-1788 and Positron Emission Tomography Pharmacopsychiatry. 19: 2-3. DOI: 10.1055/S-2007-1017137 |
0.264 |
|
| 2001 |
Okugawa G, Agartz I, Nordström M, Sedvall G. Quantitative volumetric MRI of the posterior superior vermis in chronic schizophrenia Neuroimage. 13: 1083. DOI: 10.1016/S1053-8119(01)92412-7 |
0.263 |
|
| 2002 |
Okugawa G, Sedvall G, Nordström M, Andreasen N, Pierson R, Magnotta V, Agartz I. Selective reduction of the posterior superior vermis in men with chronic schizophrenia. Schizophrenia Research. 55: 61-7. PMID 11955964 DOI: 10.1016/S0920-9964(01)00248-1 |
0.263 |
|
| 1981 |
Borg S, Kvande H, Sedvall G. Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science (New York, N.Y.). 213: 1135-7. PMID 7268421 DOI: 10.1126/Science.7268421 |
0.263 |
|
| 2002 |
Jönsson EG, Flyckt L, Burgert E, Crocq M-, Forslund KL, Mattila-Evenden M, Rylander G, Åsberg M, Nimaonkar VL, Edman G, Bjerkentstedt L, Wiesel F-, Sedvall G. Association study and meta-analysis of a DRD3 gene Ser9Gly variant and schizophrenia European Psychiatry. 17: 182. DOI: 10.1016/S0924-9338(02)80782-9 |
0.263 |
|
| 2000 |
Mirsky AF, Bieliauskas LA, French LM, Van Kammen DP, Jönsson E, Sedvall G. A 39-year followup of the Genain quadruplets. Schizophrenia Bulletin. 26: 699-708. PMID 10993407 DOI: 10.1093/Oxfordjournals.Schbul.A033487 |
0.262 |
|
| 1989 |
Grebb JA, Browning MD, Valverius P, Borg S, Sedvall G, Greengard P. An analysis of postmortem brain samples from 32 alcoholic and nonalcoholic individuals for protein III, a neuronal phosphoprotein. Alcoholism, Clinical and Experimental Research. 13: 673-9. PMID 2688467 DOI: 10.1111/J.1530-0277.1989.TB00403.X |
0.261 |
|
| 1986 |
Frankenhaeuser M, Lundberg U, Rauste von Wright M, von Wright J, Sedvall G. Urinary monoamine metabolites as indices of mental stress in healthy males and females. Pharmacology, Biochemistry, and Behavior. 24: 1521-5. PMID 2426718 DOI: 10.1016/0091-3057(86)90478-8 |
0.261 |
|
| 2001 |
Agartz I, Nordström M, Okugawa G, Sedvall G. Reliability and reproducibility of brain tissue segmentation and volumetry of MR scans Neuroimage. 13: 1023. DOI: 10.1016/S1053-8119(01)92358-4 |
0.261 |
|
| 1983 |
Swahn CG, Sedvall G. Identification and determination of 1-methylimidazole-4-acetic acid in human cerebrospinal fluid by gas chromatography-mass spectrometry. Journal of Neurochemistry. 40: 688-96. PMID 6827268 DOI: 10.1111/J.1471-4159.1983.Tb08034.X |
0.261 |
|
| 1984 |
Ehrin E, Johnström P, Stone-Elander S, Nilsson JL, Persson A, Farde L, Sedvall G, Litton JE, Eriksson L, Widén L. Preparation and preliminary positron emission tomography studies of 11C-Ro 15-1788, a selective benzodiazepine receptor antagonist. Acta Pharmaceutica Suecica. 21: 183-8. PMID 6093432 |
0.26 |
|
| 1976 |
Alfredsson G, Wode-Helgodt B, Sedvall G. A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF. Psychopharmacology. 48: 123-31. PMID 826923 DOI: 10.1007/Bf00423250 |
0.26 |
|
| 1975 |
Beck O, Sedvall G. The synthesis of 5-hydroxyindole-3-(-2-D2-acetic acid) and α,α′,β,β′-D4-5-hyoroxytryptamine Journal of Labelled Compounds. 11: 57-61. DOI: 10.1002/JLCR.2590110108 |
0.26 |
|
| 2001 |
Hurd YL, Suzuki M, Sedvall GC. D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain. Journal of Chemical Neuroanatomy. 22: 127-37. PMID 11470560 DOI: 10.1016/S0891-0618(01)00122-3 |
0.259 |
|
| 1999 |
Hurd YL, Keller E, Sotonyi P, Sedvall G. Preprotachykinin-A mRNA expression in the human and monkey brain: An in situ hybridization study. The Journal of Comparative Neurology. 411: 56-72. PMID 10404107 DOI: 10.1002/(Sici)1096-9861(19990816)411:1<56::Aid-Cne5>3.0.Co;2-3 |
0.259 |
|
| 1977 |
Alfredsson G, Wiesel FA, Fyro B, Sedvall G. Mass fragmentographic analysis of clomipramine and its mono-demethylated metabolite in human plasma. Psychopharmacology. 52: 25-30. PMID 403553 DOI: 10.1007/Bf00426595 |
0.258 |
|
| 1983 |
Borg S, Czarnecka A, Kvande H, Mossberg D, Sedvall G. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. Alcoholism, Clinical and Experimental Research. 7: 411-5. PMID 6362467 DOI: 10.1111/J.1530-0277.1983.Tb05496.X |
0.258 |
|
| 1977 |
Wode-Helgodt B, Eneroth P, Fyrö B, Gullberg B, Sedvall G. Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients. Acta Psychiatrica Scandinavica. 56: 280-93. PMID 335789 DOI: 10.1111/J.1600-0447.1977.Tb00229.X |
0.257 |
|
| 1967 |
Nybäck H, Sedvall G, Kopin IJ. Accelerated synthesis of dopamine-C14 from tyrosine-C14 in rat brain after chlorpromazine. Life Sciences. 6: 2307-12. PMID 6060277 DOI: 10.1016/0024-3205(67)90040-9 |
0.257 |
|
| 1986 |
Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study. Journal of Psychiatric Research. 20: 19-29. PMID 2423688 DOI: 10.1016/0022-3956(86)90020-8 |
0.257 |
|
| 1996 |
Härnryd C, Jönsson E, Greitz D, Johannesson T, Nyman H, Wahlström J, Sedvall G. A monozygotic schizophrenic triplet European Psychiatry. 11: 259s. DOI: 10.1016/0924-9338(96)88774-8 |
0.256 |
|
| 2002 |
Agartz I, Okugawa G, Sedvall G. Reliability and reproducibility of MR brain tissue segmentation European Psychiatry. 17: 111. DOI: 10.1016/S0924-9338(02)80496-5 |
0.255 |
|
| 1989 |
Grind M, Nilsson MI, Nilsson L, Oxenstierna G, Sedvall G, Wahlén A. Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers. Psychopharmacology. 98: 304-9. PMID 2568653 DOI: 10.1007/BF00451679 |
0.255 |
|
| 1993 |
Lindefors N, Lindén A, Brené S, Sedvall G, Persson H. CCK peptides and mRNA in the human brain. Progress in Neurobiology. 40: 671-90. PMID 8484007 DOI: 10.1016/0301-0082(93)90010-P |
0.255 |
|
| 1975 |
Sedvall G, Fyrö B, Nybäck H, Wiesel FA. Actions of dopaminergic antagonists in the striatum. Advances in Neurology. 9: 131-40. PMID 238375 |
0.254 |
|
| 2007 |
Sedvall G. A quest for antipsychotic drug actions in the brain: personal experiences from 50 years of neuropsychiatric research at Karolinska Institutet. Physiology & Behavior. 92: 238-44. PMID 17631363 DOI: 10.1016/j.physbeh.2007.05.060 |
0.253 |
|
| 2002 |
Jönsson EG, Norton N, Forslund K, Mattila-Evenden M, Rylander G, Åsberg M, Owen MJ, Sedvall G. Association between a functional promoter MAOA variant and schizophrenia European Psychiatry. 17: 182. DOI: 10.1016/S0924-9338(02)80781-7 |
0.253 |
|
| 1973 |
FYRÖ B, WODE-HELGODT B, BORG S, SEDVALL G. HOMOVANILLIC ACID IN CEREBROSPINAL FLUID OF SCHIZOPHRENIC PATIENTS BEFORE AND DURING CiHLORPROMAZINE TREATMENT Acta Psychiatrica Scandinavica. 49: 54-54. DOI: 10.1111/J.1600-0447.1973.TB10479.X |
0.253 |
|
| 1985 |
Bjerkenstedt L, Edman G, Flyckt L, Hagenfeldt L, Sedvall G, Wiesel FA. Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patients. Psychopharmacology. 87: 253-9. PMID 3936081 DOI: 10.1007/Bf00432703 |
0.252 |
|
| 2003 |
Jönsson EG, Sillén A, Vares M, Ekholm B, Terenius L, Sedvall GC. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 119: 28-34. PMID 12707934 DOI: 10.1002/ajmg.b.20004 |
0.252 |
|
| 1984 |
Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA. Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. Journal of Neurochemistry. 42: 833-7. PMID 6198473 DOI: 10.1111/J.1471-4159.1984.Tb02756.X |
0.252 |
|
| 1980 |
Almay BG, Johansson F, von Knorring L, Sedvall G, Terenius L. Relationships between CSF levels of endorphins and monoamine metabolites in chronic pain patients. Psychopharmacology. 67: 139-42. PMID 6154301 DOI: 10.1007/Bf00431968 |
0.251 |
|
| 1983 |
Beck O, Borg S, Sedvall G. Tryptophan levels in human cerebrospinal fluid after acute and chronic ethanol consumption. Drug and Alcohol Dependence. 12: 217-22. PMID 6653393 DOI: 10.1016/0376-8716(83)90063-7 |
0.249 |
|
| 1984 |
Härnryd C, Bjerkenstedt L, Gullberg B, Oxenstierna G, Sedvall G, Wiesel FA. Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients. Acta Psychiatrica Scandinavica. Supplementum. 311: 75-92. PMID 6199950 |
0.249 |
|
| 1974 |
Fri CG, Wiesel FA, Sedvall G. Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography. Life Sciences. 14: 2469-80. PMID 4549970 DOI: 10.1016/0024-3205(74)90143-X |
0.247 |
|
| 1978 |
Grimm VE, Sedvall G. Difference in cerebellar norepinephrine metabolism in jumping and non-jumping mice. Life Sciences. 22: 2017-23. PMID 672443 DOI: 10.1016/0024-3205(78)90548-9 |
0.247 |
|
| 1995 |
Sedvall G. S-28-3 Receptor binding studies in schizophrenia European Neuropsychopharmacology. 5: 239-240. DOI: 10.1016/0924-977X(95)90290-T |
0.247 |
|
| 1996 |
Hurd Y, Pauli S, Sedvall G. Imaging the gene expression of opioid peptides in the post-mortem human brain European Neuropsychopharmacology. 6: 158. DOI: 10.1016/0924-977X(96)88036-9 |
0.246 |
|
| 1983 |
Borg S, Kvande H, Mossberg D, Valverius P, Sedvall G. Central nervous system noradrenaline metabolism and alcohol consumption in man. Pharmacology, Biochemistry, and Behavior. 18: 375-8. PMID 6634849 DOI: 10.1016/0091-3057(83)90202-2 |
0.245 |
|
| 1980 |
Johansson F, von Knorring L, Sedvall G, Terenius L. Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin reuptake inhibitor (zimelidine) in chronic pain patients. Psychiatry Research. 2: 167-72. PMID 6158065 DOI: 10.1016/0165-1781(80)90073-6 |
0.245 |
|
| 2003 |
Jönsson EG, Flyckt L, Burgert E, Crocq MA, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Nimgaonkar VL, Edman G, Bjerkenstedt L, Wiesel FA, Sedvall GC. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatric Genetics. 13: 1-12. PMID 12605094 DOI: 10.1097/00041444-200303000-00001 |
0.244 |
|
| 1973 |
Anggård E, Sjöquist B, Fyrö B, Sedvall G. Quantitative determination of homovanillic acid in serum by mass fragmentography. European Journal of Pharmacology. 24: 37-42. PMID 4756167 DOI: 10.1016/0014-2999(73)90111-8 |
0.243 |
|
| 1979 |
Muskiet FA, Jeuring HJ, Korf J, Sedvall G, Westerink BH, Teelken AW, Wolthers BG. Correlations between a fluorimetric and mass fragmentographic method for the determination of 3-methoxy-4-hydroxyphenylacetic acid and two mass fragmentographic methods for the determination of 3-methoxy-4- hydroxyphenylethylene glycol in cerebrospinal fluid. Journal of Neurochemistry. 32: 191-4. PMID 759571 DOI: 10.1111/J.1471-4159.1979.Tb04527.X |
0.24 |
|
| 1978 |
Bjerkenstedt L, Härnryd C, Grimm V, Gullberg B, Sedvall G. A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS. Archiv Fã¼R Psychiatrie Und Nervenkrankheiten. 226: 157-72. PMID 32861 DOI: 10.1007/Bf00341708 |
0.238 |
|
| 1965 |
Sedvall G, Thorson J. Adrenergic transmission at vasoconstrictor nerve terminals partially depleted of noradrenaline. Acta Physiologica Scandinavica. 64: 251-8. PMID 5855022 DOI: 10.1111/j.1748-1716.1965.tb04175.x |
0.238 |
|
| 1984 |
Farde L, Sedvall G. [Swedish research in frontline. Positron emission tomography shows the brain's receptor functions in psychiatric diseases]. Lã¤Kartidningen. 81: 4519-21. PMID 6097782 |
0.237 |
|
| 1964 |
SEDVALL G. SHORT TERM EFFECTS OF RESERPINE ON NORADRENALINE LEVELS IN SKELETAL MUSCLE. Acta Physiologica Scandinavica. 62: 101-8. PMID 14210249 DOI: 10.1111/j.1748-1716.1964.tb03956.x |
0.237 |
|
| 1983 |
Alfredsson G, Sedvall G. Rapid high-performance liquid chromatographic method for the assay of glutamine in human cerebrospinal fluid. Journal of Chromatography. 274: 325-30. PMID 6874834 DOI: 10.1016/S0378-4347(00)84437-0 |
0.237 |
|
| 1981 |
Swahn CH, Sedvall G. Identification and determination of tele-methylhistamine in cerebrospinal fluid by gas chromatography-mass spectrometry. Journal of Neurochemistry. 37: 461-6. PMID 7264669 DOI: 10.1111/J.1471-4159.1981.Tb00478.X |
0.237 |
|
| 1964 |
Fuxe K, Sedvall G. Histochemical And Biochemical Observations On The Effect Of Reserpine On Noradrenaline Storage In Vasoconstrictor Nerves. Acta Physiologica Scandinavica. 61: 121-129. PMID 14168031 DOI: 10.1111/J.1748-1716.1964.Tb02947.X |
0.236 |
|
| 2003 |
Jönsson EG, Abou Jamra R, Schumacher J, Flyckt L, Edman G, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Bjerkenstedt L, Wiesel FA, Propping P, Cichon S, Nöthen MM, Sedvall GC. No association between a putative functional promoter variant in the dopamine beta-hydroxylase gene and schizophrenia. Psychiatric Genetics. 13: 175-8. PMID 12960750 DOI: 10.1097/01.ypg.0000066964.66429.ce |
0.236 |
|
| 1995 |
Jönsson E, Forsell C, Lannfelt L, Sedvall G. Schizophrenia and APP gene mutations. Biological Psychiatry. 37: 135-6. PMID 7718679 DOI: 10.1016/0006-3223(94)00211-K |
0.235 |
|
| 1988 |
Berrettini WH, Oxenstierna G, Sedvall G, Nurnberger JI, Gold PW, Rubinow DR, Goldin LR. Characteristics of cerebrospinal fluid neuropeptides relevant to clinical research. Psychiatry Research. 25: 349-59. PMID 3186863 DOI: 10.1016/0165-1781(88)90104-7 |
0.233 |
|
| 2003 |
Williams NM, Norton N, Williams H, Ekholm B, Hamshere ML, Lindblom Y, Chowdari KV, Cardno AG, Zammit S, Jones LA, Murphy KC, Sanders RD, McCarthy G, Gray MY, Jones G, ... ... Sedvall G, et al. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. American Journal of Human Genetics. 73: 1355-67. PMID 14628288 DOI: 10.1086/380206 |
0.233 |
|
| 1992 |
Hall H, Litton JE, Halldin C, Kopp J, Sedvall G. Studies on the binding of [3H]flumazenil and [3H]sarmazenil in post-mortem human brain Human Psychopharmacology. 7: 367-377. DOI: 10.1002/Hup.470070602 |
0.232 |
|
| 1993 |
Fredrikson M, Wik G, Greitz T, Eriksson L, Stone-Elander S, Ericson K, Sedvall G. Regional cerebral blood flow during experimental phobic fear. Psychophysiology. 30: 126-30. PMID 8416057 DOI: 10.1111/J.1469-8986.1993.Tb03211.X |
0.23 |
|
| 1997 |
Geijer T, Jönsson E, Neiman J, Gyllander A, Sedvall G, Rydberg U, Terenius L. Prodynorphin allelic distribution in Scandinavian chronic alcoholics. Alcoholism, Clinical and Experimental Research. 21: 1333-6. PMID 9347097 DOI: 10.1111/J.1530-0277.1997.Tb04456.X |
0.23 |
|
| 1980 |
Grimm VE, Bartfai T, Palmskog G, Sedvall G. Possible correlation between noradrenergic innervation in the cerebellum and jumping behavior in mice. Neuroscience. 5: 373-8. PMID 7374948 DOI: 10.1016/0306-4522(80)90112-8 |
0.23 |
|
| 1973 |
Sedvall G, Mayevsky A, Samuel D, Fri C. Oxygen 18 in measurement of dopamine turnover in rat brain Life Sciences. 13: cxlv-cxlvi. DOI: 10.1016/0024-3205(73)90392-5 |
0.23 |
|
| 1988 |
Hagenfeldt L, Oxenstierna G, Alfredsson G, Edman G, Iselius L, Sedvall G. A twin study of amino acid concentrations in cerebrospinal fluid. Journal of Psychiatric Research. 22: 51-6. PMID 3397910 DOI: 10.1016/0022-3956(88)90028-3 |
0.229 |
|
| 1999 |
Jönsson EG, Nimgaonkar VL, Zhang XR, Shaw SH, Burgert E, Crocq MA, Chakravarti A, Sedvall GC. Trend for an association between schizophrenia and D3S1310, a marker in proximity to the dopamine D3 receptor gene. American Journal of Medical Genetics. 88: 352-7. PMID 10402502 DOI: 10.1002/(Sici)1096-8628(19990820)88:4<352::Aid-Ajmg12>3.0.Co;2-0 |
0.228 |
|
| 2014 |
Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG. Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis. Behavioral and Brain Functions : Bbf. 10: 26. PMID 25073638 DOI: 10.1186/1744-9081-10-26 |
0.226 |
|
| 2010 |
Annerbrink K, Jönsson EG, Olsson M, Nilsson S, Sedvall GC, Anckarsäter H, Eriksson E. Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and monoamine metabolite concentrations in cerebrospinal fluid. Psychiatry Research. 179: 231-4. PMID 20483169 DOI: 10.1016/j.psychres.2009.04.018 |
0.224 |
|
| 1968 |
Sedvall G, Jönsson B, Pettersson U, Levin K. Effects of lithium salts on plasma protein bound iodine and uptake of I131 in thyroid gland of man and rat Life Sciences. 7: 1257-1264. DOI: 10.1016/0024-3205(68)90239-7 |
0.221 |
|
| 1965 |
Dahlström A, Fuxe K, Kernell D, Sedvall G. Reduction of the monoamine stores in the terminals of bulbospinal neurones following stimulation in the medulla oblongata. Life Sciences. 4: 1207-12. PMID 5840099 DOI: 10.1016/0024-3205(65)90334-6 |
0.221 |
|
| 1989 |
Nybäck H, Nordberg A, Långström B, Halldin C, Hartvig P, Ahlin A, Swahn CG, Sedvall G. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Progress in Brain Research. 79: 313-9. PMID 2587749 |
0.221 |
|
| 1979 |
Swahn CG, Beving H, Sedvall G. Mass fragmentographic determination of 4-amino-3-p-chlorophenylbutyric acid (baclofen) in cerebrospinal fluid and serum. Journal of Chromatography. 162: 433-8. PMID 528610 DOI: 10.1016/S0378-4347(00)81532-7 |
0.22 |
|
| 1990 |
Gandy SE, Grebb JA, Rosen N, Albert KA, Devinsky O, Blumberg H, Anderson N, Cedarbaum JM, Porter RJ, Sedvall G. General assay for phosphoproteins in cerebrospinal fluid: a candidate marker for paraneoplastic cerebellar degeneration. Annals of Neurology. 28: 829-33. PMID 2285268 DOI: 10.1002/Ana.410280616 |
0.22 |
|
| 1965 |
FUXE K, SEDVALL G. THE DISTRIBUTION OF ADRENERGIC NERVE FIBRES TO THE BLOOD VESSELS IN SKELETAL MUSCLE. Acta Physiologica Scandinavica. 64: 75-86. PMID 14347281 DOI: 10.1111/j.1748-1716.1965.tb04155.x |
0.215 |
|
| 1996 |
SEDVALL G. NORADRENALINE STORAGE IN SKELETAL MUSCLE. Acta Physiologica Scandinavica. 60: 39-50. PMID 14131829 DOI: 10.1111/J.1748-1716.1964.TB02867.X |
0.214 |
|
| 1978 |
Swahn C, Beving H, Sedvall G. Synthesis of 4-amino-3-p-chlorophenyl-butyric acid-2, 2, 4, 4-2H4 (baclofen) Journal of Labelled Compounds and Radiopharmaceuticals. 15: 739-745. DOI: 10.1002/JLCR.2580150189 |
0.212 |
|
| 1977 |
Sedvall G, Bjerkenstedt L, Swahn CG, Wiesel FA, Wode-Helgodt B. Mass fragmentography to study dopamine metabolism. Advances in Biochemical Psychopharmacology. 16: 343-8. PMID 883547 |
0.211 |
|
| 1983 |
Widen L, Blomqvist G, Greitz T, Litton JE, Bergström M, Ehrin E, Ericson K, Eriksson L, Ingvar DH, Johansson L, Nilsson JL, Stone-Elander S, Sedvall G, Wiesel F, Wiik G. PET studies of glucose metabolism in patients with schizophrenia. Ajnr. American Journal of Neuroradiology. 4: 550-2. PMID 6136180 |
0.208 |
|
| 1964 |
KERNELL D, SEDVALL G. REDUCTION OF THE NORADRENALINE CONTENT OF SKELETAL MUSCLE BY SYMPATHETIC STIMULATION. Acta Physiologica Scandinavica. 61: 201-2. PMID 14168042 DOI: 10.1111/j.1748-1716.1964.tb02957.x |
0.208 |
|
| 2011 |
Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 700-4. PMID 21295953 DOI: 10.1016/j.euroneuro.2010.12.008 |
0.205 |
|
| 1998 |
Jönsson EG, Nöthen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P, Sedvall GC. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiatry Research. 79: 1-9. PMID 9676821 DOI: 10.1016/S0165-1781(98)00027-4 |
0.205 |
|
| 1998 |
Jönsson EG, Dahl ML, Roh HK, Jerling M, Sedvall GC. Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophrenia. Psychiatric Genetics. 8: 25-8. PMID 9564684 |
0.203 |
|
| 1996 |
Jönsson E, Nöthen MM, Gustavsson JP, Neidt H, Brené S, Tylec A, Propping P, Sedvall G. DRD4 polymorphisms and personality traits in a Swedish sample of healthy volunteers Psychiatric Genetics. 6: 165. DOI: 10.1097/00041444-199623000-00082 |
0.202 |
|
| 1996 |
Jönsson E, Brené S, Lindblad K, Sharara S, Sedvall G, Schalling M. Lack of expansion of cytosine adenine guanine trinucleotide repeat in the dentatorubral and pallidoluysian atrophy gene in Swedish schizophrenic patients. Biological Psychiatry. 40: 228-9. PMID 8830958 DOI: 10.1016/0006-3223(96)00037-6 |
0.202 |
|
| 1984 |
Bjerkenstedt L, Edman G, Flyckt L, Sedvall G, Wiesel F. CLINICAL AND BIOCHEMICAL EFFECTS OF CITALOPAM IN DEPRESSED PATIENTS Clinical Neuropharmacology. 7: S470. DOI: 10.1097/00002826-198406001-00433 |
0.201 |
|
| 1991 |
Persson A, d'Argy R, Gillberg PG, Halldin C, Litton JL, Swahn CG, Sedvall G. Autoradiography and saturation experiments with 11C-RO 15-1788 binding to human brain. Acta Radiologica. Supplementum. 376: 169-70. PMID 1666768 |
0.201 |
|
| 1973 |
Fyrö B, Petterson U, Sedvall G. Pharmacokinetics of lithium in manic-depressive patients. Acta Psychiatrica Scandinavica. 49: 237-47. PMID 4715069 DOI: 10.1111/J.1600-0447.1973.Tb04417.X |
0.195 |
|
| 1968 |
Nybäck H, Sedvall G. Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain. The Journal of Pharmacology and Experimental Therapeutics. 162: 294-301. PMID 5666984 |
0.193 |
|
| 1978 |
Frankenhaeuser M, von Wright MR, Collins A, von Wright J, Sedvall G, Swahn CG. Sex differences in psychoneuroendocrine reactions to examination stress. Psychosomatic Medicine. 40: 334-43. PMID 684135 DOI: 10.1097/00006842-197806000-00006 |
0.192 |
|
| 1994 |
Swahn CG, Halldin C, Farde L, Sedvall G. Metbabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC Human Psychopharmacology. 9: 25-31. |
0.188 |
|
| 2006 |
Agartz I, Sedvall GC, Terenius L, Kulle B, Frigessi A, Hall H, Jönsson EG. BDNF gene variants and brain morphology in schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 141: 513-23. PMID 16741916 DOI: 10.1002/ajmg.b.30338 |
0.187 |
|
| 1969 |
Sedvall G, Jönsson B, Petterson U. Evidence Of An Altered Thyroid Function In Man During Treatment With Lithium Carbonate Acta Psychiatrica Scandinavica. 44: 59-67. DOI: 10.1111/J.1600-0447.1969.Tb02045.X |
0.185 |
|
| 1997 |
Geijer T, Jönsson E, Neiman J, Persson ML, Brené S, Gyllander A, Sedvall G, Rydberg U, Wasserman D, Terenius L. Tyrosine hydroxylase and dopamine D4 receptor allelic distribution in Scandinavian chronic alcoholics. Alcoholism, Clinical and Experimental Research. 21: 35-9. PMID 9046370 |
0.185 |
|
| 1968 |
Nybäck H, Sedvall G. Influence of drugs on catecholamine metabolism in brain as studied by 14C-tyrosine. British Journal of Pharmacology. 34: 220P-221P. PMID 5676022 |
0.182 |
|
| 2015 |
Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis. Psychiatry Research. 229: 497-504. PMID 26142836 DOI: 10.1016/j.psychres.2015.06.023 |
0.182 |
|
| 1989 |
Persson A, Pauli S, Halldin C, Stone-Elander S, Farde L, Sjogren I, Sedvall G. Saturation analysis of specific 11C Ro 15-1788 binding to the human neocortex using positron emission tomography Human Psychopharmacology. 4: 21-31. |
0.182 |
|
| 1996 |
Jönsson E, Nöthen MM, Bunzel R, Propping P, Sedvall G. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347: 1831. PMID 8667938 |
0.182 |
|
| 2000 |
Jönsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Journal of Psychiatric Research. 34: 239-44. PMID 10867119 DOI: 10.1016/S0022-3956(00)00013-3 |
0.18 |
|
| 1973 |
Fyrö B, Petterson U, Sedvall G. Time course for the effect of lithium on thyroid function in men and women. Acta Psychiatrica Scandinavica. 49: 230-6. PMID 4123663 DOI: 10.1111/J.1600-0447.1973.Tb04416.X |
0.175 |
|
| 2000 |
Buervenich S, Carmine A, Arvidsson M, Xiang F, Zhang Z, Sydow O, Jönsson EG, Sedvall GC, Leonard S, Ross RG, Freedman R, Chowdari KV, Nimgaonkar VL, Perlmann T, Anvret M, et al. NURR1 mutations in cases of schizophrenia and manic-depressive disorder. American Journal of Medical Genetics. 96: 808-13. PMID 11121187 DOI: 10.1002/1096-8628(20001204)96:6<808::Aid-Ajmg23>3.0.Co;2-E |
0.172 |
|
| 1984 |
Alfredsson G, Bjerkenstedt L, Edman G, Härnryd C, Oxenstierna G, Sedvall G, Wiesel FA. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine. Acta Psychiatrica Scandinavica. Supplementum. 311: 49-74. PMID 6199949 |
0.169 |
|
| 2000 |
Sedvall G. C03.01 Human brain imaging course European Psychiatry. 15: 268s-269s. DOI: 10.1016/S0924-9338(00)94161-0 |
0.166 |
|
| 1975 |
Sedvall GC. Chlorpromazine and brain catecholamine synthesis. Psychopharmacology Bulletin. 11: 60. PMID 237303 |
0.165 |
|
| 1989 |
Persson A, Pauli S, Swahn CG, Halldin C, Sedvall G. Cerebral uptake of 11C-Ro 15-1788 and its acid metabolite 11C-Ro 15-3890; PET study in healthy volunteers Human Psychopharmacology. 4: 215-220. |
0.163 |
|
| 2010 |
Andreou D, Saetre P, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG. Tryptophan hydroxylase gene 1 (TPH1) variants associated with cerebrospinal fluid 5-hydroxyindole acetic acid and homovanillic acid concentrations in healthy volunteers. Psychiatry Research. 180: 63-7. PMID 20580984 DOI: 10.1016/j.psychres.2009.11.018 |
0.161 |
|
| 1986 |
Sedvall G. Neuropharmacology and the human brain. Acta Psychiatrica Scandinavica. Supplementum. 327: 11-8. PMID 2875612 |
0.161 |
|
| 2005 |
Tamagaki C, Sedvall GC, Jönsson EG, Okugawa G, Hall H, Pauli S, Agartz I. Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study. The American Journal of Psychiatry. 162: 2315-21. PMID 16330596 DOI: 10.1176/appi.ajp.162.12.2315 |
0.159 |
|
| 1992 |
Sedvall G. Current status of PET scanning in schizophrenia Neuropsychopharmacology. 7: 73-75. |
0.157 |
|
| 1998 |
Jönsson EG, Geijer T, Gyllander A, Terenius L, Sedvall GC. Failure to replicate an association between a rare allele of a tyrosine hydroxylase gene microsatellite and schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 248: 61-3. PMID 9684913 DOI: 10.1007/s004060050018 |
0.154 |
|
| 2006 |
Jönsson EG, Edman-Ahlbom B, Sillén A, Gunnar A, Kulle B, Frigessi A, Vares M, Ekholm B, Wode-Helgodt B, Schumacher J, Cichon S, Agartz I, Sedvall GC, Hall H, Terenius L. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 30: 924-33. PMID 16581172 DOI: 10.1016/j.pnpbp.2006.02.008 |
0.153 |
|
| 2005 |
Fleischhacker WW, Keet IPM, Kahn RS, Hummer M, Peuskens J, Hranov LG, Libiger J, Dollfus S, Gaebel W, Davidson M, Galderisi S, Boter H, Rybakowski J, Gheorghe M, Ibor JJL, ... Sedvall G, et al. The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial Schizophrenia Research. 78: 147-156. PMID 16055308 DOI: 10.1016/J.Schres.2005.06.004 |
0.151 |
|
| 1994 |
Halldin C, Wikstrom H, Swahn CG, Sedvall G, Stjernlof P, Farde L. Preparation of [propyl-11C]OSU 191, a highly potent and selective 5- HT(1A) agonist for PET Journal of Labelled Compounds and Radiopharmaceuticals. 35: 494-495. |
0.151 |
|
| 2018 |
Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals. Psychiatry Research. 263: 30-34. PMID 29482043 DOI: 10.1016/j.psychres.2018.02.036 |
0.15 |
|
| 2003 |
Okugawa G, Sedvall GC, Agartz I. Smaller cerebellar vermis but not hemisphere volumes in patients with chronic schizophrenia. The American Journal of Psychiatry. 160: 1614-7. PMID 12944335 DOI: 10.1176/appi.ajp.160.9.1614 |
0.148 |
|
| 2002 |
Okugawa G, Sedvall GC, Agartz I. Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 252: 120-3. PMID 12192469 DOI: 10.1007/s00406-002-0370-9 |
0.148 |
|
| 1967 |
Sedvall GC, Kopin IJ. Acceleration of norepinephrine synthesis in the rat submaxillary gland in vivo during sympathetic nerve stimulation. Life Sciences. 6: 45-51. PMID 6030556 DOI: 10.1016/0024-3205(67)90360-8 |
0.145 |
|
| 1980 |
Sedvall GC, Wode-Helgodt B. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients. Archives of General Psychiatry. 37: 1113-6. PMID 6158928 |
0.145 |
|
| 1997 |
Jönsson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M, Owen MJ, Sedvall GC. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. European Archives of Psychiatry and Clinical Neuroscience. 247: 297-302. PMID 9477008 DOI: 10.1007/Bf02922258 |
0.143 |
|
| 1989 |
Melander T, Bartfai T, Brynne N, Consolo S, Fisone G, Hokfelt T, Kohler C, Nordstrom O, Norheim-Theodorsson E, Persson A, Sedvall G, Staines WA, Wu CF. Galanin in the cholinergic basal forebrain: histochemical, autoradiographic and in vivo studies Progress in Brain Research. 79: 85-91. PMID 2479959 DOI: 10.1016/S0079-6123(08)62467-X |
0.138 |
|
| 2006 |
Laywer G, Nyman H, Agartz I, Arnborg S, Jönsson EG, Sedvall GC, Hall H. Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression. Bmc Psychiatry. 6: 31. PMID 16901336 DOI: 10.1186/1471-244X-6-31 |
0.137 |
|
| 1988 |
Wik G, Borg S, Sjögren I, Wiesel FA, Blomqvist G, Borg J, Greitz T, Nybäck H, Sedvall G, Stone-Elander S. PET determination of regional cerebral glucose metabolism in alcohol-dependent men and healthy controls using 11C-glucose. Acta Psychiatrica Scandinavica. 78: 234-41. PMID 2851920 |
0.136 |
|
| 2003 |
Jönsson EG, Norton N, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Owen MJ, Sedvall GC. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophrenia Research. 61: 31-7. PMID 12648733 DOI: 10.1016/S0920-9964(02)00224-4 |
0.135 |
|
| 1984 |
Härnryd C, Bjerkenstedt L, Björk K, Gullberg B, Oxenstierna G, Sedvall G, Wiesel FA, Wik G, Aberg-Wistedt A. Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazine. Acta Psychiatrica Scandinavica. Supplementum. 311: 7-30. PMID 6367364 |
0.132 |
|
| 2001 |
Jönsson EG, Ivo R, Forslund K, Mattila-Evenden M, Rylander G, Cichon S, Propping P, Nöthen MM, Åsberg M, Sedvall GC. No association between DRD4-521C/T variant and schizophrenia American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 618. |
0.13 |
|
| 2002 |
Jönsson EG, Damberg M, Forslund K, Mattila-Evenden M, Rylander G, Asberg M, Oreland L, Sedvall GC. No association between a transcription factor Activating Protein 2beta (AP-2beta) gene variant and schizophrenia. Neuroscience Letters. 330: 290-2. PMID 12270648 DOI: 10.1016/S0304-3940(02)00818-2 |
0.127 |
|
| 1977 |
Sedvall G. [Treatment of schizophrenia. Clinical pharmacological viewpoint]. Lã¤Kartidningen. 74: 2196-8. PMID 875529 |
0.126 |
|
| 1973 |
Sedvall G, Mayevsky A, Fri CG, Sjöquist B, Samuel D. The use of stable oxygen isotopes for labeling of homovanillic acid in rat brain in vivo. Advances in Biochemical Psychopharmacology. 7: 57-68. PMID 4742808 |
0.125 |
|
| 1980 |
Sedvall G. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs. Progress in Biochemical Pharmacology. 16: 133-40. PMID 6160594 |
0.124 |
|
| 1997 |
Thome J, Jönsson E, Foley P, Harsányi A, Sedvall G, Riederer P. Ciliary neurotrophic factor null mutation and schizophrenia in a Swedish population. Psychiatric Genetics. 7: 79-82. PMID 9285965 DOI: 10.1097/00041444-199722000-00004 |
0.124 |
|
| 1996 |
Sedvall G. Human brain imaging — A force for psychiatry and psychopharmacology European Psychiatry. 11: 255s. DOI: 10.1016/0924-9338(96)88767-0 |
0.121 |
|
| 1994 |
Brene S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue The Journal of Neuroscience. 14: 985-998. DOI: 10.1523/JNEUROSCI.14-03-00985.1994 |
0.119 |
|
| 1998 |
Jönsson EG, Zhang F, Nimgaonkar VL, Rudert WA, Sedvall GC. Lack of association between schizophrenia and HLA DQB1 alleles in a Swedish sample. Schizophrenia Research. 29: 293-6. PMID 9516671 DOI: 10.1016/S0920-9964(97)00104-7 |
0.119 |
|
| 2001 |
Jönsson EG, Nöthen MM, Gustavsson JP, Berggård C, Bunzel R, Forslund K, Rylander G, Mattila-Evenden M, Propping P, Asberg M, Sedvall G. No association between serotonin 2A receptor gene variants and personality traits. Psychiatric Genetics. 11: 11-7. PMID 11409694 DOI: 10.1097/00041444-200103000-00003 |
0.118 |
|
| 2000 |
Radu D, Sedvall G. W04.05 Ethics of Psychiatric Postmortem Brain Research European Psychiatry. 15: 282s-282s. DOI: 10.1016/S0924-9338(00)94229-9 |
0.118 |
|
| 1981 |
Sedvall G. Serotonin metabolite concentrations in cerebrospinal fluid from schizophrenic patients -- relationships to family history. Advances in Experimental Medicine and Biology. 133: 719-25. PMID 6172022 |
0.118 |
|
| 1996 |
Jönsson E, Lannfelt L, Engvall B, Sedvall G. Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. European Archives of Psychiatry and Clinical Neuroscience. 246: 182-4. PMID 8832195 DOI: 10.1007/BF02188951 |
0.117 |
|
| 2003 |
Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S, Becker T, Freudenberg J, Jönsson EG, Mattila-Evenden M, Sedvall GC, Czerski PM, Kapelski P, Hauser J, Maier W, et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. American Journal of Human Genetics. 73: 1438-43. PMID 14618545 DOI: 10.1086/379928 |
0.116 |
|
| 1975 |
Sedvall G. [New treatment of schizophrenia?]. Lã¤Kartidningen. 72: 451. PMID 235059 |
0.113 |
|
| 1980 |
Wiesel FA, Alfredsson G, Ehrnebo M, Sedvall G. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. European Journal of Clinical Pharmacology. 17: 385-91. PMID 7418717 |
0.113 |
|
| 2005 |
Ekholm B, Ekholm A, Adolfsson R, Vares M, Osby U, Sedvall GC, Jönsson EG. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nordic Journal of Psychiatry. 59: 457-64. PMID 16316898 DOI: 10.1080/08039480500360906 |
0.113 |
|
| 1982 |
Wiesel FA, Fyrö B, Nybäck H, Sedvall G, Wode-Helgodt B. Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidity. Biological Psychiatry. 17: 1403-13. PMID 6186299 |
0.109 |
|
| 1979 |
Belmaker RH, Ebstein RP, Dasberg H, Levy A, Sedvall G, Van Praag HM. The effect of propranolol treatment in shizophrenia on CSF amine metabolites and prolactin. Psychopharmacology. 63: 293-6. PMID 113817 |
0.108 |
|
| 2005 |
Glaser B, Schumacher J, Williams HJ, Jamra RA, Ianakiev N, Milev R, Ohlraun S, Schulze TG, Czerski PM, Hauser J, Jönsson EG, Sedvall GC, Klopp N, Illig T, Becker T, et al. No association between the putative functional ZDHHC8 single nucleotide polymorphism rs175174 and schizophrenia in large European samples. Biological Psychiatry. 58: 78-80. PMID 15992527 DOI: 10.1016/J.Biopsych.2005.03.017 |
0.107 |
|
| 2006 |
Vares M, Ekholm A, Sedvall GC, Hall H, Jönsson EG. Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures. Psychopathology. 39: 286-95. PMID 16960467 DOI: 10.1159/000095733 |
0.107 |
|
| 2002 |
Arnborg S, Agartz I, Hall H, Jönsson E, Sillén A, Sedvall G. Data mining in schizophrenia research - Preliminary analysis Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2431: 27-38. |
0.104 |
|
| 1972 |
Sedvall G, Nybäck H. [Neuroleptic therapy in schizophrenia]. Nordisk Psykiatrisk Tidsskrift. Nordic Journal of Psychiatry. 26: 323-40. PMID 4404495 |
0.104 |
|
| 1988 |
Wiesel FA, Farde L, Sedvall G, Wik G. The application of positron emission tomography in psychiatry Nordic Journal of Psychiatry. 42: 107-110. DOI: 10.3109/08039488809103214 |
0.104 |
|
| 1980 |
Sedvall G, Fyrö B, Gullberg B, Nybäck H, Wiesel FA, Wode-Helgodt B. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. The British Journal of Psychiatry : the Journal of Mental Science. 136: 366-74. PMID 6155965 |
0.102 |
|
| 1985 |
von Holst H, Lindquist C, Sedvall G. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage. Acta Neurochirurgica. 77: 146-51. PMID 2416192 |
0.098 |
|
| 1967 |
Sedvall GC, Kopin IJ. Influence of sympathetic denervation and nerve impulse activity of tyrosine hydroxylase in the rat submaxillary gland Biochemical Pharmacology. 16: 39-46. DOI: 10.1016/0006-2952(67)90183-9 |
0.098 |
|
| 2001 |
Buervenich S, Xiang F, Sydow O, Jönsson EG, Sedvall GC, Anvret M, Olson L. Identification of four novel polymorphisms in the calcitonin/alpha-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression. Human Mutation. 17: 435-6. PMID 11317366 DOI: 10.1002/humu.1126 |
0.098 |
|
| 1982 |
Alfredsson G, Lindberg M, Sedvall G. The presence of 7-hydroxychlorpromazine in CSF of chloropromazine-treated patients. Psychopharmacology. 77: 376-8. PMID 6813900 |
0.096 |
|
| 1997 |
Sedvall GC. [Promising effects of the new antipsychotic agents in schizophrenia. But recommendations of the Medical Products Agency are conservative]. Lã¤Kartidningen. 94: 1873-6. PMID 9190476 |
0.096 |
|
| 1980 |
Sedvall G. Relationships among biochemical, clinical, and pharmacokinetic variables in neuroleptic-treated schizophrenic patients. Advances in Biochemical Psychopharmacology. 24: 521-8. PMID 6105798 |
0.096 |
|
| 2002 |
Sedvall G. Mapping positive and negative symptoms using brain imaging European Psychiatry. 17: 54. DOI: 10.1016/S0924-9338(02)80243-7 |
0.089 |
|
| 1999 |
Gustavsson JP, Nöthen MM, Jönsson EG, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, Sedvall GC, Propping P, Asberg M. No association between serotonin transporter gene polymorphisms and personality traits. American Journal of Medical Genetics. 88: 430-6. PMID 10402513 DOI: 10.1002/(SICI)1096-8628(19990820)88:4<430::AID-AJMG23>3.0.CO;2-1 |
0.085 |
|
| 1978 |
Wode-Helgodt B, Sedvall G. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women. Communications in Psychopharmacology. 2: 177-83. PMID 668302 |
0.083 |
|
| 1972 |
Sedvall G. [Clinico-pharmacological aspects of prescription of sedatives and hypnotics]. Lã¤Kartidningen. 69: 1373-7. PMID 5026559 |
0.083 |
|
| 1991 |
Angst J, Bech P, Bobon D, Engel R, Hippius H, Janzen GJ, Lecrubier Y, Lingjaerde O, Moller HJ, Montgomery S, Paes de Sousa M, Rossi A, Saletu B, Sedvall G, Stefanis C, et al. Report on the third Consensus Conference on the methodology of clinical trials with antipsychotic drugs Pharmacopsychiatry. 24: 149-152. PMID 1685571 DOI: 10.1055/S-2007-1014459 |
0.08 |
|
| 1969 |
Kopin IJ, Weise VK, Sedvall GC. Effect of false transmitters on norepinephrine synthesis. The Journal of Pharmacology and Experimental Therapeutics. 170: 246-52. PMID 4311320 |
0.08 |
|
| 1995 |
Jönsson E, Björck E, Wahlström J, Gustavsson P, Sedvall G. Screening for CGG trinucleotide repeat expansion in the fragile X mental retardation 1 gene in schizophrenic patients. Psychiatric Genetics. 5: 157-60. PMID 8750357 |
0.079 |
|
| 1996 |
Lidén S, Reizenstein P, Sedvall G, Ehn L. [A study and treatment of a group of patients with electro-hypersensitivity. More than half of the patients were able to return to work]. Lã¤Kartidningen. 93: 2265-8. PMID 8649122 |
0.078 |
|
| 1997 |
Jönsson EG, Härnryd C, Johannesson T, Wahlström J, Bergenius J, Bergstedt H, Greitz D, Nyman H, Björck E, Blennow E, Sedvall GC. Further studies on a male monozygotic triplet with schizophrenia: cytogenetical and neurobiological assessments in the patients and their parents. European Archives of Psychiatry and Clinical Neuroscience. 247: 239-47. PMID 9444492 |
0.077 |
|
| 1984 |
Bartfai A, Edman G, Levander SE, Schalling D, Sedvall G. Bilateral skin conductance activity, clinical symptoms and CSF monoamine metabolite levels in unmedicated schizophrenics, differing in rate of habituation. Biological Psychology. 18: 201-18. PMID 6204697 DOI: 10.1016/0301-0511(84)90003-6 |
0.077 |
|
| 1995 |
Härnryd C, Jönsson E, Greitz D, Nyman H, Sedvall G. A set of male monozygotic triplets with schizophrenic psychoses: nature or nurture? European Archives of Psychiatry and Clinical Neuroscience. 245: 1-7. PMID 7786906 DOI: 10.1007/BF02191537 |
0.076 |
|
| 1984 |
Sedvall G, Iselius L, Nybäck H, Oreland L, Oxenstierna G, Ross SB, Wiesel FA. Genetic studies of CSF monoamine metabolites. Advances in Biochemical Psychopharmacology. 39: 79-85. PMID 6205565 |
0.076 |
|
| 1982 |
Hallert C, Allenmark S, Larsson-Cohn U, Sedvall G. High level of pyridoxal 5'-phosphate in the cerebrospinal fluid of adult celiac patients. The American Journal of Clinical Nutrition. 36: 851-4. PMID 6182788 |
0.076 |
|
| 1968 |
Sedvall GC, Weise VK, Kopin IJ. The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity. The Journal of Pharmacology and Experimental Therapeutics. 159: 274-82. PMID 5638648 |
0.074 |
|
| 1972 |
Sedvall G. [Neuroleptics in the treatment of psychoses]. Lã¤Kartidningen. 69: 78-84. PMID 4664128 |
0.062 |
|
| 1987 |
Jacobson B, Eklund G, Hamberger L, Linnarsson D, Sedvall G, Valverius M. Perinatal origin of adult self-destructive behavior. Acta Psychiatrica Scandinavica. 76: 364-71. PMID 3425362 |
0.058 |
|
| 1983 |
Bartfai A, Levander SE, Sedvall G. Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients. Biological Psychiatry. 18: 971-87. PMID 6196060 |
0.057 |
|
| 1967 |
Wurtman RJ, Axelrod J, Sedvall G, Moore RY. Photic and neural control of the 24-hour norepinephrine rhythm in the rat pineal gland. The Journal of Pharmacology and Experimental Therapeutics. 157: 487-92. PMID 6048008 |
0.054 |
|
| 1983 |
Bartfai A, Levander S, Edman G, Schalling D, Sedvall G. Skin conductance responses in unmedicated recently admitted schizophrenic patients. Psychophysiology. 20: 180-7. PMID 6844517 |
0.048 |
|
| 1997 |
Jönsson EG, Mirsky AF, Johannesson T, Wahlström J, Bieliauskas LA, van Kammen DP, Sedvall GC. No cytogenetical abnormalities in a set of schizophrenic quadruplets. Biological Psychiatry. 42: 1186-7. PMID 9426891 |
0.046 |
|
| 1983 |
Hallert C, Sedvall G. Improvement in central monoamine metabolism in adult coeliac patients starting a gluten-free diet. Psychological Medicine. 13: 267-71. PMID 6192458 |
0.045 |
|
| 1991 |
Duelfer T, Johnstrom P, Stone-Elander S, Holland A, Halldin C, Haaparanta M, Solin O, Bergman J, Steinman M, Sedvall G. The labelling of 2-oxoquazepam with electrophilic 18F Journal of Labelled Compounds and Radiopharmaceuticals. 29: 1223-1239. |
0.044 |
|
| 1969 |
Anggård E, Sedvall G. Gas chromatography of catecholamine metabolites using electron capture detection and mass spectrophotometry. Analytical Chemistry. 41: 1250-6. PMID 5797316 |
0.044 |
|
| 1982 |
Hallert C, Aström J, Sedvall G. Psychic disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and signs of depression. Scandinavian Journal of Gastroenterology. 17: 25-8. PMID 6182605 |
0.04 |
|
| 2001 |
Jönsson EG, Nöthen MM, Gustavsson JP, Berggård C, Bunzel R, Forslund K, Rylander G, Mattila-Evenden M, Propping P, Åsberg M, Sedvall G. Association study between 5-HT2a polymorphisms and personality traits American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 626. |
0.034 |
|
| 1989 |
Angst J, Bech P, Boyer P, Bruinvels J, Engel R, Helmchen H, Hippius H, Lingjaerde O, Racagni G, Saletu B, Sedvall G, Silverstone JT, Stefanis CN, Stoll K, Woggon B. Consensus conference on the methodology of clinical trials of antidepressants, Zurich, March 1988: Report of the Consensus Committee Pharmacopsychiatry. 22: 3-7. |
0.033 |
|
| 2002 |
Sedvall GC. Internationalization of psychiatric research - the prospective for the European Association of Psychiatrists. Acta Psychiatrica Scandinavica. 105: 321-3. PMID 11942938 DOI: 10.1034/j.1600-0447.2002.2e004.x |
0.03 |
|
| 1971 |
Ljunggren JG, Sedvall G, Levin K, Fyrö B. Influence of the lithium ion on the biosynthesis of thyroxine and thyroglobulin in the rat. Acta Endocrinologica. 67: 784-92. PMID 4104311 |
0.024 |
|
| 1993 |
Häfner H, Sedvall G, Angst J. Today's perspective on Kraepelin's nosology of endogenous psychoses European Archives of Psychiatry and Clinical Neuroscience. 243: 164-170. PMID 8117760 DOI: 10.1007/BF02190723 |
0.024 |
|
| 1965 |
GIACOBINI E, SEDVALL G, UVNAES B. PHOSPHATIDASE A ACTIVITY OF ISOLATED RAT MAST CELLS AND OF RED BLOOD CELLS, WHITE BLOOD CELLS AND SPINAL GANGLION CELLS. Experimental Cell Research. 37: 368-75. PMID 14298949 |
0.02 |
|
| 1990 |
Sedvall G. Special symposium on Remoxipride: Introduction Acta Psychiatrica Scandinavica, Supplement. 82: 3. |
0.017 |
|
| 1969 |
Sedvall G. [Therapy of anxiety, mental anguish and sleeplessness. 3. Clinical pharmacological viewpoints]. Lã¤Kartidningen. 66: Suppl 1:59-72. PMID 4389476 |
0.012 |
|
| 2000 |
Sedvall G, Terenius L. Editorial Brain Research Reviews. 31: 105. DOI: 10.1016/S0165-0173(99)00026-0 |
0.01 |
|
| 1978 |
Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica. Supplementum. 5-27. PMID 277059 |
0.01 |
|
| 1976 |
Wode-Helgodt B, Alfredsson G, Borg S, Fyrö B, Sedvall G. Klinisk behandlingseffekt av klorpromazin och några farmakokinetiska och farmakodynamiska parametrar Nordisk Psykiatrisk Tidsskrift. 30: 500-506. DOI: 10.3109/08039487609097397 |
0.01 |
|
| 1973 |
Petterson U, Fyrö B, Sedvall G. A new scale for the longitudinal rating of manic states. Acta Psychiatrica Scandinavica. 49: 248-56. PMID 4715070 |
0.01 |
|
| Hide low-probability matches. |
